JP7627566B2 - Culture material and its uses - Google Patents
Culture material and its uses Download PDFInfo
- Publication number
- JP7627566B2 JP7627566B2 JP2020213855A JP2020213855A JP7627566B2 JP 7627566 B2 JP7627566 B2 JP 7627566B2 JP 2020213855 A JP2020213855 A JP 2020213855A JP 2020213855 A JP2020213855 A JP 2020213855A JP 7627566 B2 JP7627566 B2 JP 7627566B2
- Authority
- JP
- Japan
- Prior art keywords
- culture
- cells
- pores
- cell
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims description 36
- 239000011148 porous material Substances 0.000 claims description 154
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 claims description 96
- 238000000034 method Methods 0.000 claims description 93
- 229920005989 resin Polymers 0.000 claims description 74
- 239000011347 resin Substances 0.000 claims description 74
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 70
- 239000001301 oxygen Substances 0.000 claims description 70
- 229910052760 oxygen Inorganic materials 0.000 claims description 70
- -1 polyethylene terephthalate Polymers 0.000 claims description 42
- 229920000642 polymer Polymers 0.000 claims description 34
- 239000004793 Polystyrene Substances 0.000 claims description 24
- 238000012258 culturing Methods 0.000 claims description 23
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 20
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 20
- 210000000056 organ Anatomy 0.000 claims description 19
- 239000002861 polymer material Substances 0.000 claims description 16
- 229920005992 thermoplastic resin Polymers 0.000 claims description 13
- 229920002223 polystyrene Polymers 0.000 claims description 12
- 229910010272 inorganic material Inorganic materials 0.000 claims description 11
- 239000011147 inorganic material Substances 0.000 claims description 11
- 229920005615 natural polymer Polymers 0.000 claims description 8
- 229920001059 synthetic polymer Polymers 0.000 claims description 8
- 239000011247 coating layer Substances 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 152
- 239000010408 film Substances 0.000 description 48
- 238000004113 cell culture Methods 0.000 description 45
- 238000006116 polymerization reaction Methods 0.000 description 42
- 239000000306 component Substances 0.000 description 37
- 239000000243 solution Substances 0.000 description 29
- 239000002609 medium Substances 0.000 description 28
- 230000002503 metabolic effect Effects 0.000 description 24
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 23
- 210000003494 hepatocyte Anatomy 0.000 description 22
- 108010035532 Collagen Proteins 0.000 description 19
- 102000008186 Collagen Human genes 0.000 description 19
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 19
- 229920001436 collagen Polymers 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 19
- 229920001577 copolymer Polymers 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 19
- 239000007789 gas Substances 0.000 description 18
- 238000011282 treatment Methods 0.000 description 17
- 239000000178 monomer Substances 0.000 description 16
- 150000001336 alkenes Chemical class 0.000 description 15
- 238000012545 processing Methods 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 230000035699 permeability Effects 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 11
- 238000010899 nucleation Methods 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 10
- 239000004711 α-olefin Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 229920001519 homopolymer Polymers 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000000465 moulding Methods 0.000 description 8
- 229920005990 polystyrene resin Polymers 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000002834 transmittance Methods 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000005452 bending Methods 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000012986 chain transfer agent Substances 0.000 description 7
- 210000004748 cultured cell Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- ADOBXTDBFNCOBN-UHFFFAOYSA-N 1-heptadecene Chemical compound CCCCCCCCCCCCCCCC=C ADOBXTDBFNCOBN-UHFFFAOYSA-N 0.000 description 6
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 6
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 6
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 6
- 239000005977 Ethylene Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 239000000806 elastomer Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 238000005266 casting Methods 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 230000003915 cell function Effects 0.000 description 5
- 150000002148 esters Chemical group 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 150000002926 oxygen Chemical class 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 239000003505 polymerization initiator Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 4
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000007334 copolymerization reaction Methods 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000944 nerve tissue Anatomy 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 238000006068 polycondensation reaction Methods 0.000 description 4
- 229920001225 polyester resin Polymers 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 108010085895 Laminin Proteins 0.000 description 3
- 102000007547 Laminin Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000007876 drug discovery Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000009832 plasma treatment Methods 0.000 description 3
- 239000004645 polyester resin Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920005672 polyolefin resin Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 239000008215 water for injection Substances 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-dodecene Chemical compound CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 2
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920008651 Crystalline Polyethylene terephthalate Polymers 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 229920002600 TPX™ Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- ADCOVFLJGNWWNZ-UHFFFAOYSA-N antimony trioxide Chemical compound O=[Sb]O[Sb]=O ADCOVFLJGNWWNZ-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000012662 bulk polymerization Methods 0.000 description 2
- WIHMDCQAEONXND-UHFFFAOYSA-M butyl-hydroxy-oxotin Chemical compound CCCC[Sn](O)=O WIHMDCQAEONXND-UHFFFAOYSA-M 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 230000004956 cell adhesive effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000003851 corona treatment Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000011177 media preparation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 150000001451 organic peroxides Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 239000009719 polyimide resin Substances 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920000306 polymethylpentene Polymers 0.000 description 2
- 239000011116 polymethylpentene Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 238000007613 slurry method Methods 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 150000003606 tin compounds Chemical class 0.000 description 2
- LLZRNZOLAXHGLL-UHFFFAOYSA-J titanic acid Chemical compound O[Ti](O)(O)O LLZRNZOLAXHGLL-UHFFFAOYSA-J 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HSLFISVKRDQEBY-UHFFFAOYSA-N 1,1-bis(tert-butylperoxy)cyclohexane Chemical compound CC(C)(C)OOC1(OOC(C)(C)C)CCCCC1 HSLFISVKRDQEBY-UHFFFAOYSA-N 0.000 description 1
- 229940106006 1-eicosene Drugs 0.000 description 1
- FIKTURVKRGQNQD-UHFFFAOYSA-N 1-eicosene Natural products CCCCCCCCCCCCCCCCCC=CC(O)=O FIKTURVKRGQNQD-UHFFFAOYSA-N 0.000 description 1
- WAEOXIOXMKNFLQ-UHFFFAOYSA-N 1-methyl-4-prop-2-enylbenzene Chemical group CC1=CC=C(CC=C)C=C1 WAEOXIOXMKNFLQ-UHFFFAOYSA-N 0.000 description 1
- HQOVXPHOJANJBR-UHFFFAOYSA-N 2,2-bis(tert-butylperoxy)butane Chemical compound CC(C)(C)OOC(C)(CC)OOC(C)(C)C HQOVXPHOJANJBR-UHFFFAOYSA-N 0.000 description 1
- YAJYJWXEWKRTPO-UHFFFAOYSA-N 2,3,3,4,4,5-hexamethylhexane-2-thiol Chemical compound CC(C)C(C)(C)C(C)(C)C(C)(C)S YAJYJWXEWKRTPO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- BTOVVHWKPVSLBI-UHFFFAOYSA-N 2-methylprop-1-enylbenzene Chemical compound CC(C)=CC1=CC=CC=C1 BTOVVHWKPVSLBI-UHFFFAOYSA-N 0.000 description 1
- RPBWMJBZQXCSFW-UHFFFAOYSA-N 2-methylpropanoyl 2-methylpropaneperoxoate Chemical compound CC(C)C(=O)OOC(=O)C(C)C RPBWMJBZQXCSFW-UHFFFAOYSA-N 0.000 description 1
- BIISIZOQPWZPPS-UHFFFAOYSA-N 2-tert-butylperoxypropan-2-ylbenzene Chemical compound CC(C)(C)OOC(C)(C)C1=CC=CC=C1 BIISIZOQPWZPPS-UHFFFAOYSA-N 0.000 description 1
- CEBRPXLXYCFYGU-UHFFFAOYSA-N 3-methylbut-1-enylbenzene Chemical compound CC(C)C=CC1=CC=CC=C1 CEBRPXLXYCFYGU-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- GVNWZKBFMFUVNX-UHFFFAOYSA-N Adipamide Chemical compound NC(=O)CCCCC(N)=O GVNWZKBFMFUVNX-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 1
- 102000008142 Cytochrome P-450 CYP1A1 Human genes 0.000 description 1
- 108010074918 Cytochrome P-450 CYP1A1 Proteins 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229920005527 TPX™ MX001 Polymers 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- YMOONIIMQBGTDU-VOTSOKGWSA-N [(e)-2-bromoethenyl]benzene Chemical compound Br\C=C\C1=CC=CC=C1 YMOONIIMQBGTDU-VOTSOKGWSA-N 0.000 description 1
- ORLQHILJRHBSAY-UHFFFAOYSA-N [1-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1(CO)CCCCC1 ORLQHILJRHBSAY-UHFFFAOYSA-N 0.000 description 1
- ISKQADXMHQSTHK-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=C(CN)C=C1 ISKQADXMHQSTHK-UHFFFAOYSA-N 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- KJLDTYUGZVCMRD-UHFFFAOYSA-L [dodecanoyloxy(diphenyl)stannyl] dodecanoate Chemical compound C=1C=CC=CC=1[Sn+2]C1=CC=CC=C1.CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O KJLDTYUGZVCMRD-UHFFFAOYSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000011354 acetal resin Substances 0.000 description 1
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Natural products CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940058905 antimony compound for treatment of leishmaniasis and trypanosomiasis Drugs 0.000 description 1
- 150000001463 antimony compounds Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
- BSDOQSMQCZQLDV-UHFFFAOYSA-N butan-1-olate;zirconium(4+) Chemical compound [Zr+4].CCCC[O-].CCCC[O-].CCCC[O-].CCCC[O-] BSDOQSMQCZQLDV-UHFFFAOYSA-N 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- BXIQXYOPGBXIEM-UHFFFAOYSA-N butyl 4,4-bis(tert-butylperoxy)pentanoate Chemical compound CCCCOC(=O)CCC(C)(OOC(C)(C)C)OOC(C)(C)C BXIQXYOPGBXIEM-UHFFFAOYSA-N 0.000 description 1
- YMLFYGFCXGNERH-UHFFFAOYSA-K butyltin trichloride Chemical compound CCCC[Sn](Cl)(Cl)Cl YMLFYGFCXGNERH-UHFFFAOYSA-K 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 description 1
- FOTKYAAJKYLFFN-UHFFFAOYSA-N decane-1,10-diol Chemical compound OCCCCCCCCCCO FOTKYAAJKYLFFN-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- JVLRYPRBKSMEBF-UHFFFAOYSA-K diacetyloxystibanyl acetate Chemical compound [Sb+3].CC([O-])=O.CC([O-])=O.CC([O-])=O JVLRYPRBKSMEBF-UHFFFAOYSA-K 0.000 description 1
- 239000012933 diacyl peroxide Substances 0.000 description 1
- RJGHQTVXGKYATR-UHFFFAOYSA-L dibutyl(dichloro)stannane Chemical compound CCCC[Sn](Cl)(Cl)CCCC RJGHQTVXGKYATR-UHFFFAOYSA-L 0.000 description 1
- JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical compound CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 description 1
- JJPZOIJCDNHCJP-UHFFFAOYSA-N dibutyl(sulfanylidene)tin Chemical compound CCCC[Sn](=S)CCCC JJPZOIJCDNHCJP-UHFFFAOYSA-N 0.000 description 1
- NXMNIHPHNSDPTN-UHFFFAOYSA-N didodecyl(oxo)tin Chemical compound CCCCCCCCCCCC[Sn](=O)CCCCCCCCCCCC NXMNIHPHNSDPTN-UHFFFAOYSA-N 0.000 description 1
- 238000007607 die coating method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 229940069096 dodecene Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 239000012760 heat stabilizer Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003547 hepatic macrophage Anatomy 0.000 description 1
- 210000004024 hepatic stellate cell Anatomy 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010102 injection blow moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000002372 intrahepatic bile duct epithelial cell Anatomy 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- ZMCZWKGAWRLZNP-UHFFFAOYSA-N methyl-oxo-phenyltin Chemical compound C[Sn](=O)C1=CC=CC=C1 ZMCZWKGAWRLZNP-UHFFFAOYSA-N 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000651 myofibroblast Anatomy 0.000 description 1
- KYTZHLUVELPASH-UHFFFAOYSA-N naphthalene-1,2-dicarboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 KYTZHLUVELPASH-UHFFFAOYSA-N 0.000 description 1
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000005634 peroxydicarbonate group Chemical group 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001643 poly(ether ketone) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002285 poly(styrene-co-acrylonitrile) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920006350 polyacrylonitrile resin Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- FZYCEURIEDTWNS-UHFFFAOYSA-N prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=CC=C1.CC(=C)C1=CC=CC=C1 FZYCEURIEDTWNS-UHFFFAOYSA-N 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- BWJUFXUULUEGMA-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyloxy carbonate Chemical compound CC(C)OC(=O)OOC(=O)OC(C)C BWJUFXUULUEGMA-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- SWAXTRYEYUTSAP-UHFFFAOYSA-N tert-butyl ethaneperoxoate Chemical compound CC(=O)OOC(C)(C)C SWAXTRYEYUTSAP-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RWWNQEOPUOCKGR-UHFFFAOYSA-N tetraethyltin Chemical compound CC[Sn](CC)(CC)CC RWWNQEOPUOCKGR-UHFFFAOYSA-N 0.000 description 1
- 229920006259 thermoplastic polyimide Polymers 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LOAWHQCNQSFKDK-UHFFFAOYSA-N triethyltin Chemical compound CC[Sn](CC)CC.CC[Sn](CC)CC LOAWHQCNQSFKDK-UHFFFAOYSA-N 0.000 description 1
- LGANJXSGQLBREJ-UHFFFAOYSA-N triethyltin;hydrochloride Chemical compound Cl.CC[Sn](CC)CC LGANJXSGQLBREJ-UHFFFAOYSA-N 0.000 description 1
- DOOPOMANTWCTIB-UHFFFAOYSA-M tris(2-methylpropyl)stannanylium;acetate Chemical compound CC([O-])=O.CC(C)C[Sn+](CC(C)C)CC(C)C DOOPOMANTWCTIB-UHFFFAOYSA-M 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003755 zirconium compounds Chemical class 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は、培養部材およびその用途に関する。 The present invention relates to a culture member and its use.
細胞、組織、器官は、生育に適した条件下でなければ培養できないため、適切な栄養を含む培地と共にディッシュやプレート、フラスコ等の培養容器に入れ、さらに培養容器は温度・湿度・ガス濃度を所定の水準に保つことができるインキュベーター内に静置することが必要である。 Cells, tissues, and organs can only be cultured under conditions suitable for their growth, so they must be placed in a culture vessel such as a dish, plate, or flask along with a culture medium containing the appropriate nutrients, and the culture vessel must be placed in an incubator that can maintain the temperature, humidity, and gas concentration at specified levels.
さらに、上記の培養を効率的に実現するためには、充分かつ適正な酸素供給が行われなければならない。
細胞への酸素供給および培地のpH調整用の二酸化炭素供給のためには、培養容器内への酸素および二酸化炭素等のガスの供給が必要であるので、ガス透過性が低いガラスやポリスチレン等の材料からなる培養容器は、キャップおよび蓋等、培養容器上部に開口部を設けて、インキュベーター内から容器内部へのガス供給を確保している。しかし、培養細胞は通常、培養容器底面に接着している場合、もしくは、底面近傍に浮遊している場合が多く、上面は培地で覆われているので、培地中の酸素拡散速度が律速になり、特に底部の培養細胞への酸素供給は充分でなく、細胞の増殖及び成長が妨げられるという問題が古くから知られている。また、in vivoにより近い状態にしようと、細胞密度を上げて細胞培養を行うと、培養細胞への酸素供給は充分でなく、細胞の増殖及び成長が妨げられるという問題も知られている。
Furthermore, in order to efficiently carry out the above-mentioned culture, a sufficient and appropriate supply of oxygen is required.
In order to supply oxygen to cells and carbon dioxide for adjusting the pH of the culture medium, it is necessary to supply gases such as oxygen and carbon dioxide into the culture vessel, so that the culture vessel made of a material such as glass or polystyrene with low gas permeability has an opening at the top of the culture vessel, such as a cap or a lid, to ensure gas supply from inside the incubator to the inside of the vessel. However, since cultured cells are usually attached to the bottom of the culture vessel or often float near the bottom, and the top surface is covered with the culture medium, the oxygen diffusion rate in the culture medium becomes the rate limiting factor, and the supply of oxygen to the cultured cells at the bottom in particular is insufficient, which has long been known to hinder cell proliferation and growth. In addition, when cell culture is performed by increasing the cell density in order to achieve a state closer to in vivo, the supply of oxygen to the cultured cells is insufficient, which has also been known to hinder cell proliferation and growth.
細胞への酸素供給を促進するために、培養装置内の酸素分圧を高める等の手段があるが、酸素分圧をコントロールするための専用の培養装置が必要であり、一般的に大気下で培養するための培養装置と比較してコストが高い。また、酸素分圧をコントロールするために使用する酸素ボンベは支燃性ガスであるため、酸化発熱、燃焼、爆発の危険性があり、不燃性ガスである窒素ボンベや炭酸ガスボンベと比較して、酸素ボンベの取り扱いには充分注意する必要がある。
簡便かつ実用的な酸素供給改善方法として、ポリジメチルシロキサン(PDMS)(非特許文献1)、ポリブタジエン(特許文献1)のような高酸素透過度の材料を培養面に使う方法が知られている。しかし、このような高酸素透過度の材料は、強度が弱くて破けやすい場合があり、また、培地を入れた際に撓みを生じやすく、形状が不安定となる場合がある。培養器具に撓みが生じると、容器の変形、または変形に伴う衝撃によって、培養器具内壁に付着していた細胞が剥離する、撓んだ場所に培養中の細胞が集まるなど、効率的に細胞を培養できない。また、培養器具に使う材料によっては、薬剤の収着が起こりやすいため、創薬スクリーニング用途や診断用途での使用が限定されてしまう。
In order to promote the supply of oxygen to cells, there are measures such as increasing the oxygen partial pressure in the culture device, but a dedicated culture device for controlling the oxygen partial pressure is required, and it is generally more expensive than a culture device for culturing in the atmosphere. In addition, since the oxygen cylinder used to control the oxygen partial pressure is a combustion-supporting gas, there is a risk of oxidation heat generation, combustion, and explosion, and it is necessary to handle the oxygen cylinder with great care compared to nitrogen cylinders and carbon dioxide cylinders, which are non-flammable gases.
As a simple and practical method for improving oxygen supply, a method is known in which a material with high oxygen permeability, such as polydimethylsiloxane (PDMS) (Non-Patent Document 1) or polybutadiene (Patent Document 1), is used on the culture surface. However, such a material with high oxygen permeability may have low strength and may be easily broken, and may be easily bent when a culture medium is placed in the culture device, resulting in an unstable shape. When the culture device is bent, cells attached to the inner wall of the culture device may be peeled off due to deformation of the container or impact caused by the deformation, and the cells being cultured may gather at the bent area, making it impossible to culture cells efficiently. In addition, some materials used for the culture device are prone to drug sorption, which limits their use in drug discovery screening and diagnostic applications.
本発明は上記事情に鑑みてなされたものであり、優れた形状安定性、酸素供給性を有し、細胞の機能を保持したまま高密度での培養が可能である培養部材および培養器具を提供することを課題とする。 The present invention was made in consideration of the above circumstances, and aims to provide a culture component and culture device that have excellent shape stability and oxygen supply properties, and that enable high-density culture while maintaining cellular function.
本発明者らは上記課題を解決すべく鋭意検討した。その結果、以下の構成を有する培養部材などにより上記課題を解決できることを見出し、本発明を完成するに至った。本発明は、例えば以下の〔1〕~〔11〕である。
〔1〕 細胞、組織、または器官をその培養面上で培養する培養部材であり、前記培養部材は樹脂を含み、前記培養面は少なくとも1つの細孔を有する、培養部材。
〔2〕 前記樹脂が、熱可塑性樹脂である、〔1〕に記載の培養部材。
〔3〕 前記樹脂が、ポリスチレン系樹脂、ポリエチレンテレフタレート、および4-メチル―1-ペンテン重合体から選ばれる少なくとも1つである、〔1〕または〔2〕に記載の培養部材。
〔4〕 前記細孔の平均孔径が、0.1~100μmである、〔1〕~〔3〕のいずれかに記載の培養部材。
〔5〕 前記細孔の単位面積当たりの個数が、0.01~250個/cm2である、〔1〕~〔4〕のいずれかに記載の培養部材。
〔6〕 前記培養部材の形状がフィルム状またはシート状である、〔1〕~〔5〕のいずれかに記載の培養部材。
〔7〕 少なくとも培養面が、〔1〕~〔6〕のいずれかに記載の培養部材で形成された、培養器具。
〔8〕 少なくとも一つのウェルを有する、〔7〕に記載の培養器具。
〔9〕 前記培養部材の培養面に、天然高分子材料、合成高分子材料、および無機材料からなる群から選ばれる少なくとも1つの材料のコーティング層を有する、〔7〕または〔8〕に記載の培養器具。
〔10〕 〔1〕~〔6〕のいずれかに記載の培養部材の培養面に、細胞、組織または器官を接触させる工程;および
前記培養面に接触した細胞、組織または器官に酸素を供給する工程;を含む細胞、組織、または器官の培養方法。
〔11〕 前記樹脂が熱可塑性樹脂であり、前記細孔の平均孔径が0.1~100μmであり、前記細孔の単位面積当たりの個数が、0.01~250個/cm2である、〔10〕に記載の培養方法。
The present inventors have conducted extensive research to solve the above problems. As a result, they have found that the above problems can be solved by a culture device having the following configuration, and have completed the present invention. The present invention relates to, for example, the following [1] to [11].
[1] A culture member for culturing cells, tissues, or organs on its culture surface, the culture member comprising a resin, and the culture surface having at least one pore.
[2] The culture member according to [1], wherein the resin is a thermoplastic resin.
[3] The culture member according to [1] or [2], wherein the resin is at least one selected from the group consisting of polystyrene-based resins, polyethylene terephthalate, and 4-methyl-1-pentene polymers.
[4] The culture member according to any one of [1] to [3], wherein the pores have an average pore size of 0.1 to 100 μm.
[5] The culture member according to any one of [1] to [4], wherein the number of pores per unit area is 0.01 to 250 pores/cm 2 .
[6] The culture member according to any one of [1] to [5], wherein the culture member has a film-like or sheet-like shape.
[7] A culture instrument, at least a culture surface of which is formed from the culture member according to any one of [1] to [6].
[8] The culture device according to [7], having at least one well.
[9] The culture instrument according to [7] or [8], wherein the culture surface of the culture member has a coating layer made of at least one material selected from the group consisting of natural polymer materials, synthetic polymer materials, and inorganic materials.
[10] A method for culturing cells, tissues, or organs, comprising: a step of contacting a cell, tissue, or organ with the culture surface of the culture member according to any one of [1] to [6]; and a step of supplying oxygen to the cell, tissue, or organ in contact with the culture surface.
[11] The culture method according to [10], wherein the resin is a thermoplastic resin, the average pore size of the pores is 0.1 to 100 μm, and the number of the pores per unit area is 0.01 to 250 pores/cm 2 .
本発明によれば、優れた形状安定性、酸素供給性を有し、細胞の機能を保持したまま高密度での培養が可能である培養部材および培養器具を提供することができる。 The present invention provides a culture component and culture device that have excellent shape stability and oxygen supply properties, and that enable high-density culture while maintaining cellular function.
数値範囲に関する「A~B」との記載は、特に断りがなければ、A以上B以下であることを表す。例えば、「1~5%」との記載は、1%以上5%以下を意味する。 When referring to a numerical range, "A-B" means that the range is greater than or equal to A and less than or equal to B, unless otherwise specified. For example, "1-5%" means greater than or equal to 1% and less than or equal to 5%.
[培養部材]
本発明に係る(で得られる)培養部材は、その培養面で細胞、組織または器官(以下、細胞等ともいう)を培養する部材であり、前記培養部材は樹脂を含み、前記培養面は少なくとも1つの細孔を有することに特徴がある。
ここで、培養部材とは、細胞等を培養するために用いられる培養器具の少なくとも一部を構成する部材を意味する。培養部材が前記培養器具の一部である場合、少なくとも細胞等を培養する培養面が、本発明の培養部材により構成される。ここで培養面とは、細胞等を培養する際に、培地が形成される面、細胞等が播種される面、または培地が形成されかつ細胞等が播種される面を意味する。すなわち、培養面とは、培地形成予定面および細胞等播種予定面を包含する概念である。
[Culture material]
The culture member of the present invention (obtained by) is a member for culturing cells, tissues or organs (hereinafter also referred to as cells, etc.) on its culture surface, and is characterized in that the culture member contains a resin and the culture surface has at least one pore.
Here, the culture member means a member constituting at least a part of a culture instrument used for culturing cells, etc. When the culture member is a part of the culture instrument, at least the culture surface for culturing cells, etc. is constituted by the culture member of the present invention. Here, the culture surface means a surface on which a medium is formed when culturing cells, etc., a surface on which cells, etc. are seeded, or a surface on which a medium is formed and cells, etc. are seeded. In other words, the culture surface is a concept that includes a surface on which a medium is to be formed and a surface on which cells, etc. are to be seeded.
本発明の培養部材の形態は特に制限はなく、例えば、フィルム状、シート状であってもよい。前記培養部材が、フィルム状やシート状である場合には、フィルム状またはシート状の培養部材の少なくとも一面を培養面とした、培養器具として好適に用いることができる。 The form of the culture member of the present invention is not particularly limited, and may be, for example, a film or sheet. When the culture member is in the form of a film or sheet, at least one surface of the film or sheet culture member can be suitably used as a culture device as a culture surface.
本発明の培養部材は、培養面に、細胞等の足場となるための天然高分子材料、合成高分子材料、または無機材料がコーティングされていないものを意味する。 The culture member of the present invention means a member whose culture surface is not coated with a natural polymer material, synthetic polymer material, or inorganic material to serve as a scaffold for cells, etc.
本発明の培養部材の厚さは、特に制限されない。また、本発明の培養部材の厚さは、特に制限されないが、20~500μmが好ましく、25~400μmがより好ましく、50~200μmが特に好ましい。 The thickness of the culture member of the present invention is not particularly limited. In addition, the thickness of the culture member of the present invention is not particularly limited, but is preferably 20 to 500 μm, more preferably 25 to 400 μm, and particularly preferably 50 to 200 μm.
培養部材の厚さが前記範囲内であると、細孔を穿孔しやすく、強度に優れる傾向にあり、また酸素供給性に優れる傾向にある。 When the thickness of the culture member is within the above range, it tends to be easier to drill fine holes, has excellent strength, and has excellent oxygen supply properties.
本発明の培養部材を容器底面に配置してディッシュ(シャーレとも称す)、フラスコ、インサートまたはプレート等の培養器具を作製する際の培養部材の厚みは特に限定されないが、好ましくは20μm~400μm、より好ましくは20μm~300μm、さらに好ましくは20μm~200μmの厚みである。培養器具の形態に応じて適時選ばれるが、上記上下限の範囲に調整することで細胞が増殖する上で必要な適度な培地中の酸素濃度が得られやすく、充分な強度を持つ、好適な培養器具を作製しやすくなる。 When the culture member of the present invention is placed on the bottom surface of a container to produce a culture device such as a dish (also called a petri dish), flask, insert or plate, the thickness of the culture member is not particularly limited, but is preferably 20 μm to 400 μm, more preferably 20 μm to 300 μm, and even more preferably 20 μm to 200 μm. Although the thickness is appropriately selected depending on the form of the culture device, by adjusting it to the above upper and lower limit ranges, it is easy to obtain an appropriate oxygen concentration in the medium necessary for cell proliferation, and it is easy to produce a suitable culture device with sufficient strength.
本発明の培養部材は、スフェロイドの作成や細胞の足場機能向上のため、表面に細孔以外の微細加工が行われていてもよい。微細加工を施す方法として、切削加工、光リソグラフィ法、電子線直接描画法、粒子線ビーム加工法、走査プローブ加工法等、微粒子の自己組織化、またはこれらの手法によって形成されたマスタからのナノインプリント法、キャスト法、射出成形法に代表される成形加工法、めっき法等から適切に選択することができる。微細加工の形状は特に限定されるものではないが、溝の部分から山の部分までの高さが20nmから500μmであると好ましい。また、表面に微細加工がなされていない場合に比べ培養部材の最薄部の厚みを20μm迄薄くすることが可能である。 The culture member of the present invention may have a surface that is microfabricated with other features than pores in order to create spheroids or improve the scaffolding function of cells. The method of microfabrication may be appropriately selected from cutting, photolithography, direct electron beam writing, particle beam processing, scanning probe processing, etc., self-organization of fine particles, or nanoimprinting from a master formed by these methods, casting, injection molding, and other molding methods, plating, etc. The shape of the microfabrication is not particularly limited, but it is preferable that the height from the groove to the mountain is 20 nm to 500 μm. In addition, it is possible to reduce the thickness of the thinnest part of the culture member to 20 μm compared to when the surface is not microfabricated.
微細加工を行った培養部材は、マイクロ流路デバイス(マイクロ流路チップとも言う)として用いてもよい。マイクロ流路デバイスは、培養部材表面に微細加工を施して微小流路や反応容器を作成し、バイオ研究や化学工学へ応用するためのデバイスの総称である。例えば、microTAS(micro Total Analysis Systems)やLab on a Chipなどと呼ばれる装置が挙げられ、次世代の培養装置としての適用が進められている。本発明の一態様として、本発明の培養部材を含むマイクロ流路デバイスが挙げられる。 The microfabricated culture member may be used as a microchannel device (also called a microchannel chip). A microchannel device is a general term for devices in which the surface of a culture member is microfabricated to create microchannels or reaction vessels for application in bioresearch or chemical engineering. For example, devices called microTAS (micro Total Analysis Systems) or Lab on a Chip are being used, and their application as next-generation culture devices is being promoted. One aspect of the present invention is a microchannel device including the culture member of the present invention.
本発明の培養部材は、表面改質処理を行ってもよい。表面改質処理に用いる方法は特に限定されないが、例えばコロナ処理、プラズマ処理、オゾン処理、紫外線処理等の親水化処理、化学蒸着、エッチング、または、ヒドロキシル基、アミノ基、スルホン基、チオール基、カルボキシル基等の特定の官能基付加、シランカップリング等の特定の官能基による処理、酸化剤等による表面粗化等が挙げられる。これらの表面改質処理は、単独で行ってもよいし、2種以上を組み合わせて行ってもよい。なお、表面改質処理を行う場合には、少なくとも培養面に行うことが好ましい。 The culture member of the present invention may be subjected to a surface modification treatment. The method used for the surface modification treatment is not particularly limited, but examples include hydrophilization treatments such as corona treatment, plasma treatment, ozone treatment, and ultraviolet treatment, chemical vapor deposition, etching, addition of specific functional groups such as hydroxyl groups, amino groups, sulfone groups, thiol groups, and carboxyl groups, treatment with specific functional groups such as silane coupling, and surface roughening with an oxidizing agent. These surface modification treatments may be performed alone or in combination of two or more types. When performing surface modification treatment, it is preferable to perform it at least on the culture surface.
表面改質処理の中でも前記培養部材表面の濡れ性を上げ、効率的に細胞を培養できるようにするため、コロナ処理、プラズマ処理、オゾン処理、紫外線処理等の親水化処理が好ましい。培養部材表面を親水化処理することで、例えば、培養部材と細胞との密着性が良くなり、培養部材表面で細胞が均一に増殖できる。また、培養部材表面を親水化処理することで、培養器具の培養面上に天然高分子材料、合成高分子材料、または無機材料をコーティングしやすくなる。特に、培養部材表面に均一にコラーゲンを積載し、密着させやすくなり、また、コラーゲン積載処理後においても、生理食塩水による洗浄や、細胞培養の環境においてコラーゲンが剥がれず、安定な初期状態を保って細胞培養に用いることができる。プラズマ処理を行う場合には、同伴させるガスとして、窒素、水素、ヘリウム、酸素、アルゴンなどが用いられ、好ましくは、窒素、ヘリウム、アルゴンから選択される少なくとも一種のガスが選ばれる。 Among the surface modification treatments, hydrophilization treatments such as corona treatment, plasma treatment, ozone treatment, and ultraviolet treatment are preferred in order to increase the wettability of the surface of the culture member and to enable efficient cell culture. By subjecting the surface of the culture member to hydrophilization treatment, for example, the adhesion between the culture member and the cells is improved, and the cells can grow uniformly on the surface of the culture member. In addition, by subjecting the surface of the culture member to hydrophilization treatment, it becomes easier to coat the culture surface of the culture device with natural polymer materials, synthetic polymer materials, or inorganic materials. In particular, it becomes easier to uniformly load and adhere collagen to the surface of the culture member, and even after the collagen loading treatment, the collagen does not peel off when washed with physiological saline or in the cell culture environment, and can be used for cell culture while maintaining a stable initial state. When performing plasma treatment, nitrogen, hydrogen, helium, oxygen, argon, etc. are used as the gas to be accompanied, and preferably at least one gas selected from nitrogen, helium, and argon is selected.
本発明の培養部材の製造方法は、特に制限されず、製造に用いる機器も制限されない。例えば、樹脂を含む成分を含むフィルムまたはシートを形成し、必要に応じてそのフィルムまたはシートを成形して所望の形状とした成形品とし、このフィルム、シートまたは成形品に上述したように細孔を形成して培養部材を作製することができる。培養部材となるフィルム、シートまたはその他の成形品は、押出成形、溶液キャスト成形、射出成形、ブロー成形等の方法により、直接成形することによっても得られる。 The method for producing the culture member of the present invention is not particularly limited, and the equipment used for production is also not limited. For example, a film or sheet containing a component including a resin is formed, and the film or sheet is molded as necessary to form a molded product having a desired shape, and pores are formed in this film, sheet or molded product as described above to produce the culture member. The film, sheet or other molded product that will become the culture member can also be obtained by direct molding using methods such as extrusion molding, solution casting molding, injection molding, and blow molding.
前記フィルムまたはシートを形成する方法としては、具体的には、例えば、通常のインフレーション法、T-ダイ押出法などが採用される。製造は通常加温して行う。T-ダイ押出法を採用する場合、押出温度は樹脂の種類によって異なるが、100℃~400℃が好ましく、150℃~300℃が特に好ましい。また、ロール温度は20℃~100℃が好ましく、30℃~90℃が特に好ましい。 Specific methods for forming the film or sheet include, for example, the usual inflation method and T-die extrusion method. The production is usually carried out under heating. When the T-die extrusion method is used, the extrusion temperature differs depending on the type of resin, but is preferably 100°C to 400°C, and more preferably 150°C to 300°C. The roll temperature is also preferably 20°C to 100°C, and more preferably 30°C to 90°C.
また、前記フィルムまたはシートは樹脂を溶剤に溶解し樹脂や金属上に流し、レベリングしながらゆっくりと乾かしフィルム化(シート化)する溶液キャスト法で製造してもよい。用いられる溶剤は特に制限ないが、シクロヘキサン、ヘキサン、デカン、トルエンなどの炭化水素溶剤を用いてもよい。また、溶剤は、樹脂の溶解性や乾燥効率を考慮して2種類以上を混合してもよい。テーブルコート、スピンコート、ディップコート、ダイコート、スプレーコート、バーコート、ロールコート、カーテンフローコートなどの方法でポリマー溶液を塗布し、乾燥、剥離することでフィルムまたはシートに加工することができる。 The film or sheet may also be produced by a solution casting method in which the resin is dissolved in a solvent and poured onto a resin or metal, and slowly dried while leveling to form a film (sheet). There are no particular limitations on the solvent used, but hydrocarbon solvents such as cyclohexane, hexane, decane, and toluene may be used. Two or more types of solvents may also be mixed, taking into consideration the solubility of the resin and the drying efficiency. The polymer solution can be applied by a method such as table coating, spin coating, dip coating, die coating, spray coating, bar coating, roll coating, or curtain flow coating, and then dried and peeled off to process into a film or sheet.
本発明の培養部材は、細胞培養部材であることが好ましく、肝細胞培養部材であるとより好ましい。 The culture member of the present invention is preferably a cell culture member, and more preferably a hepatic cell culture member.
〈樹脂〉
本発明の培養部材を形成する材料は、樹脂を含んでいればよく、樹脂のみからなっていてもよく、樹脂を含む組成物からなっていてもよい。
前記培養部材の材料として用いられる樹脂は、細胞等に対し毒性の低いものであることが望ましく、かかる材料としては、天然樹脂でも合成樹脂でも用いることができる。成形加工性、耐薬品性の観点から、これらの中でも、合成樹脂が好ましい。また、合成樹脂は、熱可塑性樹脂でも熱硬化性樹脂でもよいが、成形が容易であることから、熱可塑性樹脂が好ましい。
<resin>
The material forming the culture component of the present invention may contain a resin, and may consist of only a resin, or may consist of a composition containing a resin.
The resin used as the material for the culture member is desirably one that is low in toxicity to cells, etc., and either natural or synthetic resins can be used as such a material. Among these, synthetic resins are preferred from the viewpoints of moldability and chemical resistance. The synthetic resin may be either a thermoplastic resin or a thermosetting resin, but thermoplastic resins are preferred because they are easy to mold.
前記培養部材の材料として用いられる樹脂は、形状安定性、薬剤収着性、自家蛍光、透明性、酸素透過性などの観点から、適切な材料を選択できる。このような観点から、培養材料を選択することにより、効率的に細胞を培養でき、創薬スクリーニング用途や診断用途で使用が可能であり、また細胞の観察も行いやすい培養部材が得られる。 The resin used as the material for the culture member can be selected appropriately from the viewpoints of shape stability, drug sorption, autofluorescence, transparency, oxygen permeability, etc. By selecting a culture material from such viewpoints, cells can be cultured efficiently, and a culture member can be obtained which can be used for drug discovery screening and diagnostic purposes, and which also allows easy observation of cells.
〈熱可塑性樹脂〉
培養部材の材料として用い得る熱可塑性樹脂としては特に限定されないが、例えば、ポリオレフィン系樹脂;ポリメタクリル酸メチル樹脂等のポリメタクリル系樹脂;ポリアクリル酸メチル樹脂等のポリアクリル系樹脂;ポリスチレン系樹脂;ポリビニルアセタール樹脂;ポリビニルブチラール樹脂;ポリビニルホルマール樹脂;ポリメチルペンテン樹脂;ポリカーボネート樹脂;ポリエーテルエーテルケトン樹脂;ポリエーテルケトン樹脂等のポリエーテル系樹脂;ポリエステル系樹脂;ナイロン-6、ナイロン-66、ポリメタキシレンアジパミド等のポリアミド系樹脂;ポリアミドイミド樹脂;ポリイミド樹脂;ポリエーテルイミド樹脂;スチレン系エラストマー;ポリオレフィン系エラストマー;ポリウレタン系エラストマー;ポリエステル系エラストマー;ポリアミド系エラストマー;ノルボルネン樹脂;ポリテトラフルオロエチレン樹脂;エチレンテトラフルオロエチレンコポリマー;ポリフッ化ビニリデン樹脂;ポリフッ化ビニル樹脂;熱可塑性ポリイミド樹脂;ポリ塩化ビニリデン樹脂;ポリ塩化ビニル樹脂;ポリ酢酸ビニル樹脂;ポリサルホン樹脂;ポリフェニレンオキシド樹脂やポリフェニレンスルフィド樹脂等のポリフェニレン系樹脂;ポリスルホン樹脂;ポリ乳酸樹脂;ポリエーテルスルホン樹脂;ポリアクリロニトリル樹脂、スチレン-アクリロニトリル共重合体樹脂等が挙げられる。
<Thermoplastic resin>
Thermoplastic resins that can be used as materials for the culture member are not particularly limited, and examples thereof include polyolefin-based resins; polymethacrylic-based resins such as polymethyl methacrylate resin; polyacrylic-based resins such as polymethyl acrylate resin; polystyrene-based resins; polyvinyl acetal resins; polyvinyl butyral resins; polyvinyl formal resins; polymethylpentene resins; polycarbonate resins; polyether ether ketone resins; polyether-based resins such as polyether ketone resins; polyester-based resins; polyamide-based resins such as nylon-6, nylon-66, and polymetaxylene adipamide; polyamideimide resins; polyimide resins; polyetherimide resins; styrene-based Examples of suitable elastomers include elastomers such as elastomers for polyolefins, elastomers for polyurethanes, elastomers for polyesters, elastomers for polyamides, norbornene resins, polytetrafluoroethylene resins, ethylene tetrafluoroethylene copolymers, polyvinylidene fluoride resins, polyvinyl fluoride resins, thermoplastic polyimide resins, polyvinylidene chloride resins, polyvinyl chloride resins, polyvinyl acetate resins, polysulfone resins, polyphenylene resins such as polyphenylene oxide resins and polyphenylene sulfide resins, polysulfone resins, polylactic acid resins, polyethersulfone resins, polyacrylonitrile resins, and styrene-acrylonitrile copolymer resins.
ポリオレフィン系樹脂としては、例えば、エチレン、プロピレン、1-ブテン、1-ヘキセン、4-メチル-1-ペンテン、1-オクテン等のα-オレフィンの単独重合体または共重合体;高圧法低密度ポリエチレン;線状低密度ポリエチレン(LLDPE);高密度ポリエチレン;ポリプロピレン;プロピレンと炭素数が2以上10以下のα-オレフィンとのランダム共重合体;エチレン・酢酸ビニル共重合体(EVA);アイオノマー樹脂等が挙げられる。
これらの中でも、成形加工性、透明性、機械的特性、通気性、軽量性、薬剤低収着性、のバランスに優れる点から、4-メチル-1-ペンテン重合体(4-メチル-1-ペンテンの単独重合体および共重合体)が好ましい。なお、本発明において、4-メチル-1-ペンテン単独重合体、および4-メチル-1-ペンテンと他のモノマーとの共重合体を総称して「4-メチル-1-ペンテン重合体」とも称する。
Examples of polyolefin resins include homopolymers or copolymers of α-olefins such as ethylene, propylene, 1-butene, 1-hexene, 4-methyl-1-pentene, and 1-octene; high-pressure low-density polyethylene; linear low-density polyethylene (LLDPE); high-density polyethylene; polypropylene; random copolymers of propylene and α-olefins having 2 to 10 carbon atoms; ethylene-vinyl acetate copolymers (EVA); and ionomer resins.
Among these, 4-methyl-1-pentene polymers (homopolymers and copolymers of 4-methyl-1-pentene) are preferred because of their excellent balance of moldability, transparency, mechanical properties, breathability, light weight, and low drug sorption. In the present invention, 4-methyl-1-pentene homopolymers and copolymers of 4-methyl-1-pentene with other monomers are also collectively referred to as "4-methyl-1-pentene polymers."
ポリスチレン系樹脂としては、例えば、スチレン系単量体(例えば、スチレン、メチルスチレン、エチルスチレン、イソプロピルスチレン、ジメチルスチレン、パラメチルスチレン、クロロスチレン、ブロモスチレン、ビニルトルエン、ビニルキシレン)の単独重合体;スチレン系単量体と、スチレン系単量体と共重合可能な単量体との共重合体(以下、「変性ポリスチレン」とも称する)が挙げられる。
スチレン系単量体と共重合可能な単量体としては、例えば、ビニル単量体(例えば、アクリロニトリル、メタクリロニトリル、アクリル酸、メタクリル酸、メタクリル酸メチル、無水マレイン酸、ブタジエン)が挙げられる。
変性ポリスチレンとしては、例えば、アクリロニトリル-スチレン共重合体(AS)、メタクリル酸メチル-スチレン共重合体、アクリロニトリルーメタクリル酸メチル-スチレン共重合体、アクリロニトリル-ブタジエン-スチレン共重合体(ABS)、アクリロニトリル-アクリルゴム-スチレン共重合体(AAS)、アクリロニトリル-エチレンプロピレンジエンゴム-スチレン共重合体(AES)が挙げられる。
これらの中でも、成形加工性、透明性、機械的特性、通気性、軽量性、薬剤低収着性、のバランスに優れる点から、スチレンの単独重合体が好ましい。
Examples of polystyrene-based resins include homopolymers of styrene-based monomers (e.g., styrene, methylstyrene, ethylstyrene, isopropylstyrene, dimethylstyrene, paramethylstyrene, chlorostyrene, bromostyrene, vinyltoluene, and vinylxylene); and copolymers of styrene-based monomers and monomers copolymerizable with styrene-based monomers (hereinafter also referred to as "modified polystyrene").
Examples of monomers copolymerizable with styrene-based monomers include vinyl monomers (eg, acrylonitrile, methacrylonitrile, acrylic acid, methacrylic acid, methyl methacrylate, maleic anhydride, and butadiene).
Examples of modified polystyrene include acrylonitrile-styrene copolymer (AS), methyl methacrylate-styrene copolymer, acrylonitrile-methyl methacrylate-styrene copolymer, acrylonitrile-butadiene-styrene copolymer (ABS), acrylonitrile-acrylic rubber-styrene copolymer (AAS), and acrylonitrile-ethylene propylene diene rubber-styrene copolymer (AES).
Among these, styrene homopolymers are preferred because they have an excellent balance of moldability, transparency, mechanical properties, breathability, light weight, and low drug sorption.
ポリエステル系樹脂としては、例えば、イソフタル酸、フタル酸、テレフタル酸、2,6-ナフタレンジカルボン酸、アジピン酸、セバシン酸などのジカルボン酸やオキシカルボン酸(例:p-オキシ安息香酸)と、エチレングリコール、プロピレングリコール、ブタンジオール、ジエチレングリコール、1,4-シクロヘキサンジメタノール、ネオペンチルグリコールなどの脂肪族グリコールとを重縮合させて得られる樹脂等が挙げられる。前記ジカルボン酸、オキシカルボン酸および脂肪族グリコールはそれぞれ、1種または2種以上を用いることができる。
前記ポリエステル系樹脂の代表的な例としては、ポリエチレンテレフタレート(PET)、ポリエチレン-2,6-ナフタレンジカルボキシレート(PEN)、ポリブチレンテレフタレート(PBT)が挙げられる。また、該樹脂は、ホモポリマーの他に、30モル%以下の第三成分を含有するコポリマーであってもよい。
これらの中でも、成形加工性、透明性、機械的特性、通気性、軽量性、薬剤低収着性、のバランスに優れる点から、ポリエチレンテレフタレートが好ましい。
Examples of polyester resins include resins obtained by polycondensation of dicarboxylic acids such as isophthalic acid, phthalic acid, terephthalic acid, 2,6-naphthalenedicarboxylic acid, adipic acid, and sebacic acid, or oxycarboxylic acids (e.g., p-oxybenzoic acid), and aliphatic glycols such as ethylene glycol, propylene glycol, butanediol, diethylene glycol, 1,4-cyclohexanedimethanol, and neopentyl glycol. One or more of the dicarboxylic acids, oxycarboxylic acids, and aliphatic glycols can be used.
Representative examples of the polyester resin include polyethylene terephthalate (PET), polyethylene-2,6-naphthalenedicarboxylate (PEN), and polybutylene terephthalate (PBT). The resin may be a homopolymer or a copolymer containing 30 mol % or less of a third component.
Among these, polyethylene terephthalate is preferred because it has an excellent balance of moldability, transparency, mechanical properties, breathability, light weight, and low drug sorption.
これらの中でも、成形加工性、透明性、機械的特性、通気性、軽量性、薬剤低収着性のバランスに優れる点から、ポリオレフィン系樹脂、ポリスチレン系樹脂、およびポリエステル系樹脂が好ましく、4-メチル-1-ペンテン重合体(4-メチル-1-ペンテンの単独重合体および共重合体)、ポリスチレン系樹脂ならびにポリエチレンテレフタレートがより好ましい。 Among these, polyolefin resins, polystyrene resins, and polyester resins are preferred because of their excellent balance of moldability, transparency, mechanical properties, breathability, light weight, and low drug sorption, and 4-methyl-1-pentene polymers (homopolymers and copolymers of 4-methyl-1-pentene), polystyrene resins, and polyethylene terephthalate are more preferred.
前記樹脂は1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 The above resins may be used alone or in combination of two or more.
熱可塑性樹脂の全光線透過率は、好ましくは70%以上、より好ましくは80%以上、さらに好ましくは90%である。該全光線透過率は、具体的には以下の方法で測定できる。
熱可塑性樹脂で構成される2mm厚の射出試験片を使用して、JISK7361に準拠して、(株)村上色彩技術研究所製のヘイズ・透過率計HM-150(D65光源)を用い、全透過光量を測定し、下記式にて全光線透過率を求める。
全光線透過率(%)=100×(全透過光量)/(入射光量)
全光線透過率が前記範囲内にあると、熱可塑性樹脂は透明性に優れる傾向にあるため、好ましい。
The total light transmittance of the thermoplastic resin is preferably 70% or more, more preferably 80% or more, and even more preferably 90%. Specifically, the total light transmittance can be measured by the following method.
Using a 2 mm thick injection test piece made of a thermoplastic resin, the total amount of transmitted light is measured in accordance with JIS K7361 using a haze/transmittance meter HM-150 (D65 light source) manufactured by Murakami Color Research Laboratory Co., Ltd., and the total light transmittance is calculated using the following formula.
Total light transmittance (%) = 100 x (total transmitted light amount) / (incident light amount)
If the total light transmittance is within the above range, the thermoplastic resin tends to have excellent transparency, which is preferable.
〈4-メチル-1-ペンテン重合体〉
以下、培養部材の材料の好適な一例である、4-メチル‐1-ペンテン重合体についてさらに詳細に説明する。
4-メチル-1-ペンテン重合体の一例である、4-メチル-1-ペンテンと、他のモノマーとの共重合体としては、ランダム共重合体、交互共重合体、ブロック共重合体、グラフト共重合体のいずれであってもよい。4-メチル-1-ペンテンと、他のモノマーとの共重合体としては、4-メチル-1-ペンテンと、エチレンおよび炭素数3~20のα-オレフィン(4-メチル-1-ペンテンを除く)から選ばれる少なくとも1種のオレフィンとの共重合体が、強度が高く、部材として用いても破れにくく割れにくく、撓みも少ないため好ましい。
<4-Methyl-1-pentene polymer>
Hereinafter, 4-methyl-1-pentene polymer, which is a suitable example of the material for the culture member, will be described in more detail.
A copolymer of 4-methyl-1-pentene and another monomer, which is an example of the 4-methyl-1-pentene polymer, may be any of a random copolymer, an alternating copolymer, a block copolymer, and a graft copolymer. As a copolymer of 4-methyl-1-pentene and another monomer, a copolymer of 4-methyl-1-pentene and at least one olefin selected from ethylene and an α-olefin having 3 to 20 carbon atoms (excluding 4-methyl-1-pentene) is preferable because it has high strength, is unlikely to break or crack, and has little deflection even when used as a member.
4-メチル-1-ペンテン重合体としては、4-メチル-1-ペンテン単独重合体並びに、4-メチル-1-ペンテンと、エチレンおよび炭素数3~20のα-オレフィン(4-メチル-1-ペンテンを除く)から選ばれる少なくとも1種のオレフィンとの共重合体から選択される少なくとも1種の重合体であることが好ましく、4-メチル-1-ペンテンと、エチレンおよび炭素数3~20のα-オレフィン(4-メチル-1-ペンテンを除く)から選ばれる少なくとも1種のオレフィンとの共重合体であることがより好ましい。 The 4-methyl-1-pentene polymer is preferably at least one polymer selected from 4-methyl-1-pentene homopolymers and copolymers of 4-methyl-1-pentene with at least one olefin selected from ethylene and α-olefins having 3 to 20 carbon atoms (excluding 4-methyl-1-pentene), and more preferably a copolymer of 4-methyl-1-pentene with at least one olefin selected from ethylene and α-olefins having 3 to 20 carbon atoms (excluding 4-methyl-1-pentene).
前記オレフィンとしては、例えば、エチレン、プロピレン、1-ブテン、1-ヘキセン、1-ヘプテン、1-オクテン、1-デセン、1-テトラデセン、1-ヘキサデセン、1-ヘプタデセン、1-オクタデセン、1-エイコセンが挙げられる。前記オレフィンは、培養部材に必要な物性に応じて適宜選択することができる。例えば、前記オレフィンとしては、適度な酸素透過度と、優れた剛性という観点からは、炭素数8~18のα-オレフィンが好ましく、1-オクテン、1-デセン、1-ドデセン、1-テトラデセン、1-ヘキサデセン、1-ヘプタデセンおよび1-オクタデセンから選ばれる少なくとも1種がより好ましい。オレフィンの炭素数が上記範囲にあると、重合体の加工性がより良好になり、クラックや端部の割れによる培養部材の外観不良が生じにくくなる傾向にある。また、培養部材の不良品発生率が低くなる。 Examples of the olefin include ethylene, propylene, 1-butene, 1-hexene, 1-heptene, 1-octene, 1-decene, 1-tetradecene, 1-hexadecene, 1-heptadecene, 1-octadecene, and 1-eicosene. The olefin can be appropriately selected according to the physical properties required for the culture member. For example, from the viewpoint of moderate oxygen permeability and excellent rigidity, the olefin is preferably an α-olefin having 8 to 18 carbon atoms, and more preferably at least one selected from 1-octene, 1-decene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-heptadecene, and 1-octadecene. When the carbon number of the olefin is within the above range, the processability of the polymer is improved, and the appearance of the culture member due to cracks or end breakage tends to be less likely to occur. In addition, the rate of defective products of the culture member is reduced.
前記オレフィンは、1種または2種以上を用いることができる。材料の強度の観点から、炭素数は2以上が好ましく、更に好ましくは炭素数10以上が更に好ましい。異なる2種以上のα-オレフィンを組み合わせる場合には、1-テトラデセンおよび1-ヘキサデセンから選ばれる少なくとも1種と、1-ヘプタデセンおよび1-オクタデセンから選ばれる少なくとも1種とを組み合わせるのが特に好ましい。 The olefins may be used alone or in combination of two or more. From the viewpoint of material strength, the carbon number is preferably 2 or more, and more preferably 10 or more. When combining two or more different α-olefins, it is particularly preferable to combine at least one selected from 1-tetradecene and 1-hexadecene with at least one selected from 1-heptadecene and 1-octadecene.
前記4-メチル-1-ペンテン重合体における4-メチル-1-ペンテンから導かれる構成単位の含有量は、好ましくは60~100モル%、より好ましくは80~98モル%である。
また、4-メチル-1-ペンテン重合体が、4-メチル-1-ペンテンと、エチレンおよび炭素数3~20のα-オレフィン(4-メチル-1-ペンテンを除く)から選ばれる少なくとも1種のオレフィンとの共重合体である場合は、その共重合体におけるエチレンおよび炭素数3~20のα-オレフィン(4-メチル-1-ペンテンを除く)から選ばれる少なくとも1種のオレフィンから導かれる構成単位の含有量は、好ましくは0~40モル%、より好ましくは2~20モル%である。なお、これら構成単位の含有量は、4-メチル-1-ペンテン重合体中の全繰返し構成単位量を100モル%とする。構成単位の含有量が上記範囲内にあると、加工性に優れ均質な培養面が得られ、またフィルムの靭性と強度のバランスが良いため、撓みも少なくなる。
The content of structural units derived from 4-methyl-1-pentene in the 4-methyl-1-pentene polymer is preferably 60 to 100 mol %, more preferably 80 to 98 mol %.
In addition, when the 4-methyl-1-pentene polymer is a copolymer of 4-methyl-1-pentene and at least one olefin selected from ethylene and an α-olefin having 3 to 20 carbon atoms (excluding 4-methyl-1-pentene), the content of the structural units derived from at least one olefin selected from ethylene and an α-olefin having 3 to 20 carbon atoms (excluding 4-methyl-1-pentene) in the copolymer is preferably 0 to 40 mol%, more preferably 2 to 20 mol%. The content of these structural units is based on the total amount of repeating structural units in the 4-methyl-1-pentene polymer being 100 mol%. When the content of the structural units is within the above range, a homogeneous culture surface with excellent processability can be obtained, and the film has a good balance between toughness and strength, so that bending is reduced.
前記4-メチル-1-ペンテン重合体は、本発明の効果を損なわない範囲で、4-メチル-1-ペンテンから導かれる構成単位および前記エチレンおよび炭素数3~20のα-オレフィンから導かれる構成単位以外の構成単位(以下「その他の構成単位」ともいう)を有してもよい。その他の構成単位の含有量は、例えば0~10.0モル%である。前記4-メチル-1-ペンテン重合体がその他の構成単位を有する場合、その他の構成単位は、1種でも2種以上であってもよい。 The 4-methyl-1-pentene polymer may have structural units (hereinafter also referred to as "other structural units") other than the structural units derived from 4-methyl-1-pentene and the structural units derived from ethylene and the α-olefin having 3 to 20 carbon atoms, within a range that does not impair the effects of the present invention. The content of the other structural units is, for example, 0 to 10.0 mol%. When the 4-methyl-1-pentene polymer has other structural units, the other structural units may be one type or two or more types.
その他の構成単位を導くモノマーとしては、例えば、環状オレフィン、芳香族ビニル化合物、共役ジエン、非共役ポリエン、官能ビニル化合物、水酸基含有オレフィン、ハロゲン化オレフィンが挙げられる。環状オレフィン、芳香族ビニル化合物、共役ジエン、非共役ポリエン、官能ビニル化合物、水酸基含有オレフィンおよびハロゲン化オレフィンとしては、例えば、特開2013-169685号公報の段落[0035]~[0041]に記載の化合物を用いることができる。 Examples of monomers that derive other structural units include cyclic olefins, aromatic vinyl compounds, conjugated dienes, non-conjugated polyenes, functional vinyl compounds, hydroxyl-containing olefins, and halogenated olefins. Examples of cyclic olefins, aromatic vinyl compounds, conjugated dienes, non-conjugated polyenes, functional vinyl compounds, hydroxyl-containing olefins, and halogenated olefins that can be used include the compounds described in paragraphs [0035] to [0041] of JP 2013-169685 A.
前記4-メチル-1-ペンテン重合体は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 The 4-methyl-1-pentene polymer may be used alone or in combination of two or more.
4-メチル-1-ペンテン重合体としては市販品を使用することもできる。具体的には、三井化学(株)製のTPX MX001、MX002、MX004、MX0020、MX021、MX321、RT18、RT31またはDX845いずれも商標)などが挙げられる。また、その他のメーカー製でも上記の要件を満たす4-メチル-1-ペンテン重合体であれば、好ましく使用できる。これらの市販品は1種単独で使用してもよく、2種以上を組み合せて使用することもできる。 Commercially available 4-methyl-1-pentene polymers can also be used. Specific examples include TPX MX001, MX002, MX004, MX0020, MX021, MX321, RT18, RT31, and DX845 (all trademarks) manufactured by Mitsui Chemicals, Inc. 4-methyl-1-pentene polymers that satisfy the above requirements from other manufacturers can also be used preferably. These commercially available products can be used alone or in combination of two or more.
4-メチル-1-ペンテン重合体は、通常、融点200℃~240℃であり耐熱性が高い。また加水分解を起こさず、耐水性、耐沸水性、耐スチーム性が優れているため、4-メチル-1-ペンテン重合体を含む培養器具等の培養部材は高圧蒸気滅菌処理が可能である。4-メチル-1-ペンテン重合体は、また可視光線透過率が高く(通常90%以上)、自家蛍光を発しない特徴を有するので、4-メチル-1-ペンテン重合体を含む培養器具は培養細胞の観察がしやすい。さらに、ほとんどの薬品に優れた耐薬品性を示し、薬剤を収着しにくいため、創薬スクリーニング用途や診断用途にも好適に用いられる。4-メチル-1-ペンテン重合体は、ヒートシールが可能であり、自材同士の熱融着のみならず他の材料との熱接着も容易である。また、熱成形が可能であるため、任意の形状の培養器具に成形することが容易であり、例えばインプリント法やインサート法を用いた成形も容易である。 4-methyl-1-pentene polymers usually have a melting point of 200°C to 240°C and are highly heat resistant. In addition, they do not undergo hydrolysis and have excellent water resistance, boiling water resistance, and steam resistance, so culture components such as culture equipment containing 4-methyl-1-pentene polymers can be sterilized with high-pressure steam. 4-methyl-1-pentene polymers also have a high visible light transmittance (usually 90% or more) and do not emit autofluorescence, so culture equipment containing 4-methyl-1-pentene polymers makes it easy to observe cultured cells. In addition, they show excellent chemical resistance to most chemicals and are not prone to sorbing drugs, so they are also suitable for use in drug discovery screening and diagnostic applications. 4-methyl-1-pentene polymers can be heat sealed, and are easy to heat-seal not only between themselves but also with other materials. In addition, they can be thermoformed, so they can be easily molded into culture equipment of any shape, and can also be easily molded using the imprint method or insert method, for example.
4-メチル-1-ペンテン重合体の、標準ポリスチレンを基準物質としたゲルパーミュエーションクロマトグラフィー(GPC)により測定される、重量平均分子量(Mw)は、好ましくは10000~2000000、より好ましくは20000~1000000、さらに好ましくは30000~500000である。ここで、GPC測定の際の試料濃度は、例えば1.0~5.0mg/mlとすることができる。また、4-メチル-1-ペンテン重合体の分子量分布(Mw/Mn)は、好ましくは1.0~30、より好ましくは1.1~25、さらに好ましくは1.1~20である。GPCで用いられる溶剤は、オルトジクロロベンゼンが好ましく用いられる。また、測定条件の一例としては、後述する実施例に示した条件が挙げられるが、該測定条件に限定されるものではない。 The weight average molecular weight (Mw) of the 4-methyl-1-pentene polymer measured by gel permeation chromatography (GPC) using standard polystyrene as a reference material is preferably 10,000 to 2,000,000, more preferably 20,000 to 1,000,000, and even more preferably 30,000 to 500,000. The sample concentration during GPC measurement can be, for example, 1.0 to 5.0 mg/ml. The molecular weight distribution (Mw/Mn) of the 4-methyl-1-pentene polymer is preferably 1.0 to 30, more preferably 1.1 to 25, and even more preferably 1.1 to 20. Orthodichlorobenzene is preferably used as the solvent for GPC. Examples of measurement conditions include those shown in the examples described below, but are not limited to these measurement conditions.
重量平均分子量(Mw)を上記上限以下とすることにより、後述する樹脂の成形法において、溶融成形で作製したフィルムは、ゲル等の不具合の発生を抑制しやすく、表面が均一な製膜をしやすくなる。また、溶液キャスト法で作製する際は溶剤への溶解性をより良好にし、フィルムのゲル等の不具合を抑制しやすく、表面均一な製膜がしやすくなる。 By setting the weight average molecular weight (Mw) to the above upper limit or less, in the resin molding method described below, the occurrence of defects such as gels in the film produced by melt molding is easily suppressed, and it is easy to produce a film with a uniform surface. In addition, when producing by a solution casting method, the solubility in the solvent is improved, and defects such as gels in the film are easily suppressed, and it is easy to produce a film with a uniform surface.
また、重量平均分子量(Mw)を上記下限以上とすることにより、培養部材は強度が十分となる傾向にある。さらに、分子量分布を上記の範囲内とすることで、作製した培養部材表面のベタツキを抑えやすく、培養部材の靭性も充分となる傾向にあり、成形時の曲げや裁断時のクラックの発生などを抑制しやすくなる。 In addition, by setting the weight-average molecular weight (Mw) to the above lower limit or higher, the culture member tends to have sufficient strength. Furthermore, by setting the molecular weight distribution within the above range, stickiness of the surface of the culture member produced tends to be suppressed, and the toughness of the culture member tends to be sufficient, making it easier to suppress bending during molding and cracks during cutting.
前記4-メチル-1-ペンテン重合体の重量平均分子量(Mw)および分子量分布(Mw/Mn)は、4-メチル-1-ペンテン重合体として、2種以上を用いた場合には、各樹脂それぞれの、MwおよびMw/Mnが、上記範囲にあればよい。 When two or more types of 4-methyl-1-pentene polymers are used, the weight average molecular weight (Mw) and molecular weight distribution (Mw/Mn) of each resin may be within the above range. When two or more types of 4-methyl-1-pentene polymers are used, the Mw and Mw/Mn of each resin may be within the above range.
4-メチル-1-ペンテン-1重合体は以上のような優れた特性を有しているので、少なくとも培養面が本発明の培養部材で形成された培養器具は、培養に悪い影響を与えることも無く、また安定性、光透過性、成形加工性が良好で、滅菌処理を行うことができるので、培養部材の材料として非常に優れている。 Because 4-methyl-1-pentene-1 polymer has the above-mentioned excellent properties, a culture device in which at least the culture surface is formed from the culture component of the present invention does not adversely affect culture, and has good stability, light transmittance, and moldability, and can be sterilized, making it an excellent material for culture components.
〈4-メチル-1-ペンテン重合体の製造方法〉
前記4-メチル-1-ペンテン重合体を製造する方法は、4-メチル-1-ペンテン、オレフィン、その他のモノマーを重合させられれば、いずれの方法であってもよい。また、分子量や分子量分布を制御するために連鎖移動剤、例えば水素を共存させてもよい。製造に用いる機器も制限されない。重合法は公知の方法でもよく、気相法、スラリー法、溶液法、バルク法であってもよい。好ましくはスラリー法、溶液法である。また、重合法は単段重合法、または二段等の多段重合法で、分子量の異なる複数の重合体を重合系中にブレンドする方法であってもよい。単段、多段重合法の何れであっても、連鎖移動剤として水素を用いる場合には、一括投入しても、分割投入、例えば重合初期、中期、終期に投入してもよい。重合は常温で行ってもよく、必要に応じて加温してもよいが、重合の効率の観点から、20℃~80℃で行うことが好ましく、40℃~60℃で行うことが特に好ましい。製造に用いる触媒も制限されないが、重合の効率の観点から、例えば国際公開公報2006/054613に記載される固体状チタン触媒成分(I)を用いることが好ましい。
<Method for producing 4-methyl-1-pentene polymer>
The method for producing the 4-methyl-1-pentene polymer may be any method capable of polymerizing 4-methyl-1-pentene, olefin, and other monomers. In addition, a chain transfer agent, such as hydrogen, may be present in order to control the molecular weight and molecular weight distribution. The equipment used for the production is not limited. The polymerization method may be a known method, and may be a gas phase method, a slurry method, a solution method, or a bulk method. The slurry method or the solution method is preferable. In addition, the polymerization method may be a single-stage polymerization method or a multi-stage polymerization method such as a two-stage polymerization method, in which a plurality of polymers having different molecular weights are blended into the polymerization system. In either the single-stage or multi-stage polymerization method, when hydrogen is used as a chain transfer agent, it may be added all at once or in portions, for example, at the initial, middle, or final stages of polymerization. The polymerization may be carried out at room temperature or may be heated as necessary. From the viewpoint of polymerization efficiency, it is preferable to carry out the polymerization at 20°C to 80°C, and it is particularly preferable to carry out the polymerization at 40°C to 60°C. There are no limitations on the catalyst used in the production, but from the viewpoint of polymerization efficiency, it is preferable to use, for example, the solid titanium catalyst component (I) described in WO 2006/054613.
〈ポリスチレン系樹脂の製造方法〉
ポリスチレン系樹脂は、例えば、以下に示す重合方法により製造することができる。
ポリスチレン系樹脂の重合方法としては、例えば、塊状重合法、溶液重合法、懸濁重合法等、公知のスチレン重合方法が挙げられる。これらの重合法は、バッチ重合法であっても連続重合法であってもよく、生産性の点から連続重合法であることが好ましい。
かかる重合法の具体例としては、例えば、スチレン系単量体、必要に応じて重合溶媒、重合開始剤、及び連鎖移動剤等を添加及び混合して、単量体類を含む原料溶液を調製する。単独或いは直列及び/又は並列に配列された2個以上の反応器と、未反応単量体等の揮発性成分を除去する脱揮工程のための脱揮装置とを備えた設備に、上記原料溶液を連続的に送入し、段階的に重合を進行させる方法が挙げられる。
<Production method of polystyrene resin>
The polystyrene resin can be produced, for example, by the polymerization method shown below.
Examples of the polymerization method for polystyrene resins include known styrene polymerization methods such as bulk polymerization, solution polymerization, suspension polymerization, etc. These polymerization methods may be batch polymerization or continuous polymerization, and continuous polymerization is preferred from the viewpoint of productivity.
A specific example of such a polymerization method is, for example, a method in which a raw material solution containing monomers is prepared by adding and mixing a styrene-based monomer and, if necessary, a polymerization solvent, a polymerization initiator, a chain transfer agent, etc., and the raw material solution is continuously fed into a facility equipped with a single reactor or two or more reactors arranged in series and/or parallel, and a devolatilizer for a devolatilization step for removing volatile components such as unreacted monomers, and polymerization is allowed to proceed stepwise.
反応器としては、例えば、完全混合型反応器、層流型反応器、重合を進行させながら一部の重合液を抜き出すループ型反応器等が挙げられる。これら反応器の配列の順序に特に制限は無い。 Examples of reactors include complete mixing reactors, laminar flow reactors, and loop reactors in which a portion of the polymerization liquid is withdrawn while the polymerization is proceeding. There are no particular limitations on the order in which these reactors are arranged.
ポリスチレン系樹脂を重合する際には、重合反応の制御の観点から、必要に応じて重合溶媒、有機過酸化物等の重合開始剤、及び連鎖移動剤を使用することができる。
重合溶媒は、一般的に重合速度や分子量等を調整するために用いられる。重合溶媒としては、特に制限はないが、例えばベンゼン、トルエン、エチルベンゼン、及びキシレン等のアルキルベンゼン類、アセトン及びメチルエチルケトン等のケトン類、並びにヘキサン及びシクロヘキサン等の脂肪族炭化水素等が挙げられる。
重合溶媒の使用量は、特に限定されるものではないが、ゲル化の制御、生産性の向上、分子量の増大等の観点から、通常、重合反応器内の重合溶液全体100質量%に対して1~50質量%であることが好ましく、3~20質量%であることがより好ましい。
When polymerizing the polystyrene resin, a polymerization solvent, a polymerization initiator such as an organic peroxide, and a chain transfer agent may be used as necessary from the viewpoint of controlling the polymerization reaction.
A polymerization solvent is generally used to adjust the polymerization rate, molecular weight, etc. The polymerization solvent is not particularly limited, and examples thereof include alkylbenzenes such as benzene, toluene, ethylbenzene, and xylene, ketones such as acetone and methyl ethyl ketone, and aliphatic hydrocarbons such as hexane and cyclohexane.
The amount of the polymerization solvent used is not particularly limited, but from the viewpoints of controlling gelation, improving productivity, increasing the molecular weight, and the like, it is usually preferably 1 to 50 mass % and more preferably 3 to 20 mass % relative to 100 mass % of the total polymerization solution in the polymerization reactor.
ポリスチレン系樹脂を得るために重合原料を重合させる際には、重合原料組成物中に、重合開始剤及び連鎖移動剤を含有させることができる。
重合開始剤としては、特に制限はないが、有機過酸化物、例えば、2,2-ビス(t-ブチルペルオキシ)ブタン、1,1-ビス(t-ブチルペルオキシ)シクロヘキサン、及びn-ブチル-4,4ービス(t-ブチルペルオキシ)バレレート等のペルオキシケタール類、ジ-t-ブチルペルオキシド、t-ブチルクミルペルオキシド、及びジクミルペルオキシド等のジアルキルペルオキシド類、アセチルペルオキシド、及びイソブチリルペルオキシド等のジアシルペルオキシド類、ジイソプロピルペルオキシジカーボネート等のペルオキシジカーボネート類、t-ブチルペルオキシアセテート等のペルオキシエステル類、アセチルアセトンペルオキシド等のケトンペルオキシド類、並びにt-ブチルヒドロペルオキシド等のヒドロペルオキシド類等を挙げることができる。
重合開始剤は、スチレン系単量体に対して0.005~0.08質量%使用することが好ましい。
連鎖移動剤としては、特に制限はないが、例えば、α-メチルスチレンダイマー、n-ドデシルメルカプタン、t-ドデシルメルカプタン、及びn-オクチルメルカプタン等を挙げることができる。
連鎖移動剤は、スチレン系単量体に対して0.01~0.50質量%使用することが好ましい。
When the polymerization raw materials are polymerized to obtain the polystyrene-based resin, a polymerization initiator and a chain transfer agent can be contained in the polymerization raw material composition.
The polymerization initiator is not particularly limited, and examples thereof include organic peroxides such as peroxyketals such as 2,2-bis(t-butylperoxy)butane, 1,1-bis(t-butylperoxy)cyclohexane, and n-butyl-4,4-bis(t-butylperoxy)valerate; dialkyl peroxides such as di-t-butyl peroxide, t-butylcumyl peroxide, and dicumyl peroxide; diacyl peroxides such as acetyl peroxide and isobutyryl peroxide; peroxydicarbonates such as diisopropyl peroxydicarbonate; peroxyesters such as t-butyl peroxyacetate; ketone peroxides such as acetylacetone peroxide; and hydroperoxides such as t-butyl hydroperoxide.
The polymerization initiator is preferably used in an amount of 0.005 to 0.08% by mass based on the styrene monomer.
The chain transfer agent is not particularly limited, but examples thereof include α-methylstyrene dimer, n-dodecyl mercaptan, t-dodecyl mercaptan, and n-octyl mercaptan.
The chain transfer agent is preferably used in an amount of 0.01 to 0.50% by mass based on the styrene monomer.
脱揮装置としては、例えば、フラッシュドラム、二軸脱揮器、薄膜蒸発器、押出機等の通常の脱揮装置を用いることができ、一般的には加熱器付きの真空脱揮槽や脱揮押出機等が用いられる。脱揮装置の配列としては、例えば、加熱器付きの真空脱揮槽を1段のみ使用したもの、加熱器付きの真空脱揮槽を直列に2段接続したもの、及び加熱器付きの真空脱揮槽と脱揮押出機とを直列に接続したもの等が挙げられる。揮発成分を極力低減するためには、加熱器付きの真空脱揮槽を直列に2段接続したもの、又は加熱器付きの真空脱揮槽と脱揮押出機とを直列に接続したものが好ましい。 As the volatilization apparatus, for example, a conventional volatilization apparatus such as a flash drum, a twin-screw volatilization apparatus, a thin-film evaporator, an extruder, etc., can be used, and generally, a vacuum volatilization tank with a heater or a volatilization extruder is used. As the arrangement of the volatilization apparatus, for example, one using only one vacuum volatilization tank with a heater, one connecting two vacuum volatilization tanks with heaters in series, and one connecting a vacuum volatilization tank with a heater and a volatilization extruder in series can be mentioned. In order to reduce the volatile components as much as possible, one connecting two vacuum volatilization tanks with heaters in series, or one connecting a vacuum volatilization tank with a heater and a volatilization extruder in series is preferable.
脱揮工程の条件は特に制限されず、例えば、ポリスチレン系樹脂の重合を塊状重合で行う場合は、最終的に未反応のスチレン系単量体が、ポリスチレン系樹脂中に好ましくは50質量%以下、より好ましくは40質量%以下になるまで重合を進めることができる。脱揮処理により、未反応物(スチレン系単量体)及び/又は溶媒等の揮発分を除去することができる。 The conditions for the devolatilization step are not particularly limited. For example, when the polymerization of polystyrene resin is carried out by bulk polymerization, the polymerization can be allowed to proceed until the final amount of unreacted styrene monomer in the polystyrene resin is preferably 50% by mass or less, more preferably 40% by mass or less. The devolatilization process can remove volatile matters such as unreacted materials (styrene monomers) and/or solvents.
脱揮処理の温度は、通常、190~280℃程度である。脱揮処理の圧力は、好ましくは0.1~50kPa、より好ましくは0.13~13kPa、更に好ましくは0.13~7kPa、特に好ましくは0.13~1.3kPaである。脱揮方法としては、例えば加熱下で減圧して脱揮する方法や、揮発成分を除去するよう設計された押出機等を通して脱揮することが望ましい。 The temperature for the devolatilization process is usually about 190 to 280°C. The pressure for the devolatilization process is preferably 0.1 to 50 kPa, more preferably 0.13 to 13 kPa, even more preferably 0.13 to 7 kPa, and particularly preferably 0.13 to 1.3 kPa. Desirable methods for devolatilization include, for example, a method in which the pressure is reduced under heating, or devolatilization through an extruder designed to remove volatile components.
〈ポリエチレンテレフタレート〉
ポリエチレンテレフタレート(PET)は、テレフタル酸およびそのエステル形成性誘導体から選ばれる少なくとも1つと、エチレングリコールおよびそのエステル形成性誘導体から選ばれる少なくとも1つとを重縮合することによって得られる重合体である。テレフタル酸のエステル形成性誘導体としては、例えば、テレフタル酸ジメチルなどのテレフタル酸のアルキルエステルなどが挙げられる。エチレングリコールのエステル形成性誘導体としては、例えば、エチレングリコール脂肪酸エステルなどの脂肪酸エステルなどが挙げられる。
<Polyethylene terephthalate>
Polyethylene terephthalate (PET) is a polymer obtained by polycondensation of at least one selected from terephthalic acid and its ester-forming derivatives with at least one selected from ethylene glycol and its ester-forming derivatives. Examples of terephthalic acid ester-forming derivatives include alkyl esters of terephthalic acid such as dimethyl terephthalate. Examples of ethylene glycol ester-forming derivatives include fatty acid esters such as ethylene glycol fatty acid esters.
ポリエチレンテレフタレートは、特性を損なわない範囲であれば、テレフタル酸およびそのエステル形成性誘導体から選ばれる少なくとも1つとともに、他のジカルボン酸およびそのエステル形成性誘導体から選ばれる少なくとも1つを共重合したものであってもよいし、エチレングリコールおよびそのエステル形成性誘導体から選ばれる少なくとも1つとともに、他のジオールおよびそのエステル形成性誘導体から選ばれる少なくとも1つを共重合したものであってもよい。共重合成分として用いられるジカルボン酸およびそのエステル形成性誘導体としては、例えば、イソフタル酸、アジピン酸、シュウ酸、セバシン酸、デカンジカルボン酸、ナフタレンジカルボン酸やこれらのアルキルエステルなどが挙げられる。また、共重合成分として用いられるジオールおよびそのエステル形成性誘導体としては、例えば、エチレングリコール、プロピレングリコール、ネオペンチルグリコール、1,5-ペンタンジオール、1,6-ヘキサンジオール、デカメチレングリコール、シクロヘキサンジメタノール、シクロヘキサンジオール、分子量400~6000のポリエチレングリコールやポリ1,3-プロピレングリコール、ポリテトラメチレングリコールなどの長鎖グリコールやこれらの脂肪酸エステルなどが挙げられる。これらの共重合成分は1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。これらの共重合成分は、ポリエチレンテレフタレートを形成する原料の20質量%以下が好ましい。 As long as the properties are not impaired, polyethylene terephthalate may be a copolymer of at least one selected from terephthalic acid and its ester-forming derivatives with at least one other dicarboxylic acid and its ester-forming derivative, or may be a copolymer of at least one selected from ethylene glycol and its ester-forming derivatives with at least one other diol and its ester-forming derivative. Examples of dicarboxylic acids and their ester-forming derivatives used as copolymerization components include isophthalic acid, adipic acid, oxalic acid, sebacic acid, decanedicarboxylic acid, naphthalenedicarboxylic acid, and alkyl esters thereof. Examples of diols and their ester-forming derivatives used as copolymerization components include ethylene glycol, propylene glycol, neopentyl glycol, 1,5-pentanediol, 1,6-hexanediol, decamethylene glycol, cyclohexanedimethanol, cyclohexanediol, polyethylene glycols having a molecular weight of 400 to 6000, long-chain glycols such as poly 1,3-propylene glycol, and polytetramethylene glycol, and fatty acid esters thereof. These copolymerization components may be used alone or in combination of two or more. These copolymerization components are preferably 20% by mass or less of the raw materials forming the polyethylene terephthalate.
〈ポリエチレンテレフタレートの製造方法〉
ポリエチレンテレフタレートは、公知の重縮合法や開環重合法などにより製造することができる。バッチ重合法および連続重合法のいずれを適用してもよいが、カルボキシル末端基量を少なくすることができ、流動性向上効果がより大きくなるという点で、連続重合法が好ましい。また、エステル交換反応および直接重合反応のいずれを適用してもよいが、コストの点で、直接重合反応が好ましい。エステル化反応、エステル交換反応および/または重縮合反応を効率よく進めるために、これらの反応時に触媒を添加することが好ましい。触媒の具体例としては、チタン酸のメチルエステル、テトラ-n-プロピルエステル、テトラ-n-ブチルエステル、テトライソプロピルエステル、テトライソブチルエステル、テトラ-tert-ブチルエステル、シクロヘキシルエステル、フェニルエステル、ベンジルエステル、トリルエステル、あるいはこれらの混合エステルなどの有機チタン化合物、ジブチルスズオキシド、メチルフェニルスズオキシド、テトラエチルスズ、ヘキサエチルジスズオキシド、シクロヘキサヘキシルジスズオキシド、ジドデシルスズオキシド、トリエチルスズハイドロオキシド、トリフェニルスズハイドロオキシド、トリイソブチルスズアセテート、ジブチルスズジアセテート、ジフェニルスズジラウレート、モノブチルスズトリクロライド、ジブチルスズジクロライド、トリブチルスズクロライド、ジブチルスズサルファイドおよびブチルヒドロキシスズオキシド、メチルスタンノン酸、エチルスタンノン酸、ブチルスタンノン酸などのアルキルスタンノン酸などのスズ化合物、ジルコニウムテトラ-n-ブトキシドなどのジルコニウム化合物、三酸化アンチモン、酢酸アンチモンなどのアンチモン化合物などが挙げられる。前記触媒は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。これらの中でも有機チタン化合物およびスズ化合物が好ましく、チタン酸のテトラ-n-ブチルエステルがより好ましい。触媒の添加量は、ポリエチレンテレフタレート100質量部に対して0.01~0.2質量部が一般的である。
<Method for producing polyethylene terephthalate>
Polyethylene terephthalate can be produced by known polycondensation methods, ring-opening polymerization methods, and the like. Either a batch polymerization method or a continuous polymerization method may be applied, but the continuous polymerization method is preferred in that the amount of carboxyl end groups can be reduced and the effect of improving fluidity is greater. Either an ester exchange reaction or a direct polymerization reaction may be applied, but the direct polymerization reaction is preferred in terms of cost. In order to efficiently proceed with the esterification reaction, the ester exchange reaction, and/or the polycondensation reaction, it is preferable to add a catalyst during these reactions. Specific examples of catalysts include organotitanium compounds such as methyl ester, tetra-n-propyl ester, tetra-n-butyl ester, tetraisopropyl ester, tetraisobutyl ester, tetra-tert-butyl ester, cyclohexyl ester, phenyl ester, benzyl ester, tolyl ester, or mixed esters of these of titanic acid, dibutyltin oxide, methylphenyltin oxide, tetraethyltin, hexaethylditin oxide, cyclohexahexylditin oxide, didodecyltin oxide, triethyltin hydrochloride, and the like. Examples of the catalyst include tin compounds such as tin oxide, triphenyltin hydroxide, triisobutyltin acetate, dibutyltin diacetate, diphenyltin dilaurate, monobutyltin trichloride, dibutyltin dichloride, tributyltin chloride, dibutyltin sulfide, and butylhydroxytin oxide; alkylstannoic acids such as methylstannoic acid, ethylstannoic acid, and butylstannoic acid; zirconium compounds such as zirconium tetra-n-butoxide; and antimony compounds such as antimony trioxide and antimony acetate. The catalyst may be used alone or in combination of two or more. Among these, organic titanium compounds and tin compounds are preferred, and tetra-n-butyl ester of titanic acid is more preferred. The amount of catalyst added is generally 0.01 to 0.2 parts by mass per 100 parts by mass of polyethylene terephthalate.
ポリエチレンテレフタレートの種類は、本発明で得られる効果を阻害しなければ特に制限されないが、機械強度や成形性の観点から、結晶性ポリエチレンテレフタレート(C-PET)が好ましい。 There are no particular limitations on the type of polyethylene terephthalate as long as it does not impede the effects of the present invention, but crystalline polyethylene terephthalate (C-PET) is preferred from the standpoint of mechanical strength and moldability.
フィルム状のポリエチレンテレフタレートを培養部材として用いる場合、フィルム状のポリエチレンテレフタレートは、延伸しても、していなくても良い。フィルム状のポリエチレンテレフタレートは、延伸すると結晶配向されるので、機械特性の観点から好ましい。延伸方法は二軸延伸が好ましい。 When a polyethylene terephthalate film is used as a culture material, the polyethylene terephthalate film may or may not be stretched. When a polyethylene terephthalate film is stretched, it undergoes crystal orientation, which is preferable from the standpoint of mechanical properties. The preferred stretching method is biaxial stretching.
なお、培養部材が樹脂を含む組成物から形成される場合には、培養部材100質量%中に、樹脂が、好ましくは90質量%以上100質量%未満であり、より好ましくは95質量%以上100質量%未満であり、特に好ましくは99質量%以上100質量%未満である。樹脂以外の成分を多量に含むと、酸素透過度の低下のみならず、透明性の低下や強度の低下を招く。 When the culture component is formed from a composition containing a resin, the resin is preferably 90% by mass or more and less than 100% by mass, more preferably 95% by mass or more and less than 100% by mass, and particularly preferably 99% by mass or more and less than 100% by mass, based on 100% by mass of the culture component. If a large amount of components other than resin are contained, not only will the oxygen permeability decrease, but the transparency and strength will also decrease.
本発明の培養部材を形成する材料は、樹脂以外の成分が含まれていてもよい。樹脂以外の成分としては、耐熱安定化剤、耐光安定化剤、加工助剤、可塑剤、酸化防止剤、滑剤、消泡剤、アンチブロック剤、着色剤、改質剤、抗菌剤、抗黴剤、防曇剤などの添加剤が挙げられる。 The material forming the culture member of the present invention may contain components other than resin. Examples of components other than resin include additives such as heat stabilizers, light stabilizers, processing aids, plasticizers, antioxidants, lubricants, defoamers, antiblocking agents, colorants, modifiers, antibacterial agents, antifungal agents, and antifogging agents.
〈細孔〉
本発明の培養部材は、その培養面に少なくとも1つの細孔を有する。ここで、培養部材における細孔とは、その培養部材中に含まれる微細な空孔であって、培養部材を貫通したものを意味し、培養部材表面加工で生じる凹凸とは異なる。
<pore>
The culture member of the present invention has at least one pore on its culture surface. Here, the pore in the culture member means a minute hole contained in the culture member and penetrating the culture member, and is different from the unevenness generated by the surface processing of the culture member.
細孔の開口形状は特に制限されず、円形状、楕円形状、正方形状、長方形状、六角形状、雲形、十字状などのいかなる形状であってもよい。加工性の観点から、これらの中でも、円形状、楕円形状であることが好ましい。本発明の培養部材が細孔を複数有する場合、複数の細孔の開口形状は、実質的に同じであってもよいし、異なってもよいが、実質的に同じであることが好ましい。 The opening shape of the pores is not particularly limited and may be any shape, such as a circle, an ellipse, a square, a rectangle, a hexagon, a cloud, or a cross. From the viewpoint of processability, among these, a circle or an ellipse is preferable. When the culture member of the present invention has a plurality of pores, the opening shapes of the plurality of pores may be substantially the same or different, but are preferably substantially the same.
細孔の数は特に制限されないが、細孔の孔密度(単位面積当たりの個数)は、0.01~250個/cm2であることが好ましく、0.1~230個/cm2であることがより好ましく、0.3~200個/cm2であることがさらに好ましい。細孔の孔密度が前記範囲内にあると、酸素供給性に優れつつ、細胞の代謝活性が高い傾向にある。 The number of pores is not particularly limited, but the pore density (number per unit area) of the pores is preferably 0.01 to 250 pores/cm 2 , more preferably 0.1 to 230 pores/cm 2 , and even more preferably 0.3 to 200 pores/cm 2. When the pore density is within the above range, the oxygen supply is excellent and the metabolic activity of the cells tends to be high.
細孔の平均孔径は特に制限されないが、0.1~100μmであることが好ましく、1~90μmであることがより好ましく、3~85μmであることがさらに好ましい。細孔の平均孔径が前記範囲内にあると、培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にある。 The average pore size of the pores is not particularly limited, but is preferably 0.1 to 100 μm, more preferably 1 to 90 μm, and even more preferably 3 to 85 μm. When the average pore size of the pores is within the above range, the medium is less likely to leak, the oxygen supply is excellent, and the metabolic activity of the cells tends to be high.
平均孔径の測定方法は特に制限されず、公知の方法を用いることができる。平均孔径の測定方法としては、例えば、ガス吸着法、水銀圧入法、バブルポイント法等により平均孔径を求める方法、マイクロスコープ、電子顕微鏡等により細孔を観察して孔径を測定し、その平均値を平均孔径とする方法、穿孔に用いる器具、例えば針、レーザービームの直径を平均孔径として推定する方法等が挙げられる。観察により孔径を測定する場合および穿孔に用いる器具の直径を平均孔径として推定する場合において、孔径とは、細孔の開口形状に対する最大内接円の直径を指し、例えば、細孔の開口形状が実質的に円形状である場合はその円の直径を指し、実質的に楕円形状である場合はその楕円の短径を指し、実質的に正方形状である場合はその正方形の辺の長さを指し、実質的に長方形状である場合はその長方形の短辺の長さを指すものである。簡便であることから、穿孔に用いる器具、例えば針、レーザービームの直径を平均孔径として推定する方法が好ましい。 The method for measuring the average pore size is not particularly limited, and known methods can be used. Examples of methods for measuring the average pore size include a method for determining the average pore size by gas adsorption, mercury intrusion, bubble point method, etc., a method for measuring the pore size by observing the pores with a microscope, electron microscope, etc., and taking the average value as the average pore size, and a method for estimating the diameter of the instrument used for perforation, such as a needle or laser beam, as the average pore size. When measuring the pore size by observation and when estimating the diameter of the instrument used for perforation as the average pore size, the pore size refers to the diameter of the maximum inscribed circle relative to the opening shape of the pore. For example, when the opening shape of the pore is substantially circular, it refers to the diameter of the circle, when it is substantially elliptical, it refers to the minor axis of the ellipse, when it is substantially square, it refers to the length of the side of the square, and when it is substantially rectangular, it refers to the length of the minor axis of the rectangle. The method for estimating the average pore size by the diameter of the instrument used for perforation, such as a needle or laser beam, is preferred because it is simple.
本発明の培養部材は、好ましくは平均孔径0.1~100μmの細孔を0.01~250個/cm2の孔密度で有し、より好ましくは平均孔径1~90μmの細孔を0.1~230個/cm2の孔密度で有し、さらに好ましくは平均孔径3~85μm細孔を0.3~200個/cm2の孔密度で有する。細孔の平均孔径および孔密度が前記範囲内にあると、酸素供給性に優れ、細胞の代謝活性が高い。 The culture member of the present invention preferably has pores with an average pore size of 0.1 to 100 μm at a pore density of 0.01 to 250 pores/cm 2 , more preferably has pores with an average pore size of 1 to 90 μm at a pore density of 0.1 to 230 pores/cm 2 , and even more preferably has pores with an average pore size of 3 to 85 μm at a pore density of 0.3 to 200 pores/cm 2. When the average pore size and pore density of the pores are within the above ranges, the oxygen supply is excellent and the metabolic activity of the cells is high.
細孔の開口面積は、好ましくは0.005~8000μm2、より好ましくは0.1~7000μm2、さらに好ましくは5~6000μm2である。細孔の開口面積が前記範囲内にあると、培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にある。 The opening area of the pores is preferably 0.005 to 8000 μm 2 , more preferably 0.1 to 7000 μm 2 , and even more preferably 5 to 6000 μm 2. When the opening area of the pores is within the above range, the medium is less likely to leak, the oxygen supply is excellent, and the metabolic activity of the cells tends to be high.
細孔の総開口面積比率(開口面積の1ウェル当たりの合計/培養部材の培養面の1ウェル当たりの総表面積×100(%))は、好ましくは0.000001~0.3%、より好ましくは0.000005~0.1%、さらに好ましくは0.00001~0.08%である。細孔の総開口面積比率が前記範囲内にあると、培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にある。 The total opening area ratio of the pores (total opening area per well/total surface area per well of the culture surface of the culture member x 100 (%)) is preferably 0.000001 to 0.3%, more preferably 0.000005 to 0.1%, and even more preferably 0.00001 to 0.08%. When the total opening area ratio of the pores is within the above range, the medium is less likely to leak, oxygen supply is excellent, and the metabolic activity of the cells tends to be high.
本発明の培養部材が細孔を複数有する場合、複数の細孔の孔径は、実質的に同じであってもよいし、ばらつきがあってもよいが、均一性が高いことが好ましい。孔径の均一性の指標として、変動係数を用いることができる。孔径の変動係数(標準偏差÷平均値×100(%))は、30%以下であることが好ましく、孔径の変動係数が20%以下であることがより好ましい。このように孔径の均一性が高いと、培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にある。 When the culture member of the present invention has multiple pores, the pore sizes of the multiple pores may be substantially the same or may vary, but it is preferable that they are highly uniform. The coefficient of variation can be used as an index of the uniformity of the pore size. The coefficient of variation of the pore size (standard deviation ÷ average value × 100 (%)) is preferably 30% or less, and more preferably 20% or less. When the pore size is highly uniform in this way, the medium is less likely to leak, the oxygen supply is excellent, and the metabolic activity of the cells tends to be high.
本発明の培養部材が細孔を複数有する場合、細孔の配置は特に制限されず、一定のパターンで配置してもよいし、ランダムに配置してもよい。一定のパターンで配置する例としては、60°千鳥、45°千鳥、並列、ヘリンボーン等が挙げられ、中心を共有する大きさの異なる複数の多角形または円を描き、それらの辺または円周上に等間隔に細孔を配列してもよい。培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にあることから、一定のパターンで配置することが好ましい。 When the culture member of the present invention has a plurality of pores, the arrangement of the pores is not particularly limited, and they may be arranged in a fixed pattern or randomly. Examples of an arrangement in a fixed pattern include 60° staggered, 45° staggered, parallel, herringbone, etc., and it is also possible to draw multiple polygons or circles of different sizes that share a common center and arrange the pores at equal intervals on their sides or circumferences. Arranging in a fixed pattern is preferable because it tends to reduce medium leakage, provide excellent oxygen supply, and increase metabolic activity of cells.
複数の細孔間の間隔は特に制限されないが、細孔の平均孔径よりも大きいことが好ましく、一定間隔であることがより好ましい。同一ウェル内の複数の細孔間の間隔は、200μm~8mmであることが好ましく、300μm~7mmであることがより好ましく、400μm~6mmであることがさらに好ましい。複数の細孔間の間隔が前記範囲内にあると、培地が漏れにくく、酸素供給性に優れつつ、細胞の代謝活性が高くなる傾向にある。 The spacing between multiple pores is not particularly limited, but is preferably larger than the average pore size of the pores, and more preferably is a constant spacing. The spacing between multiple pores in the same well is preferably 200 μm to 8 mm, more preferably 300 μm to 7 mm, and even more preferably 400 μm to 6 mm. When the spacing between multiple pores is within the above range, the medium is less likely to leak, oxygen supply is excellent, and the metabolic activity of the cells tends to be high.
複数の細孔同士は、培養部材内部において連通していてもよい。 The multiple pores may be connected to each other inside the culture member.
細孔の穿孔方法は、特に制限されず、公知の方法を用いることができる。細孔の穿孔方法としては、例えば、マイクロシリンジの様な非常に細い針を熱してフィルムに突き刺して溶解して開ける方法、レーザーを用いる方法などが挙げられる。 The method for perforating the pores is not particularly limited, and any known method can be used. Examples of methods for perforating the pores include a method in which a very thin needle such as a microsyringe is heated and pierced into the film to melt and open the pores, and a method using a laser.
レーザーには、炭酸ガスレーザー、YAGレーザー、半導体レーザー、アルゴンレーザー等の各種レーザーがあり、穿孔することができれば特に制限されない。中でも、孔径の小さい細孔の穿孔が可能であることから、波長領域100~1100nmのYAGレーザーを用いることが好ましく、可視光が透過してしまう透明材料でも吸収があり、穿孔が可能であることから、波長領域100~400mの紫外線YAGレーザーがより好ましく、波長領域260~270nmの深紫外線YAGレーザーがさらに好ましい。波長領域260~270nmの深紫外線YAGレーザーを用いる場合の出力は、10~200mWが好ましい。出力範囲が、前記範囲内であると、作業性が良く、また、過剰な照射を避けつつも、所望の径の穿孔を達成できる。 There are various types of lasers, such as carbon dioxide lasers, YAG lasers, semiconductor lasers, and argon lasers, and there are no particular limitations as long as they can drill holes. Among them, it is preferable to use a YAG laser with a wavelength range of 100 to 1100 nm, as it is possible to drill holes with a small diameter. An ultraviolet YAG laser with a wavelength range of 100 to 400 nm is more preferable, as it is absorbent and possible to drill holes even in transparent materials that transmit visible light, and a deep ultraviolet YAG laser with a wavelength range of 260 to 270 nm is even more preferable. When a deep ultraviolet YAG laser with a wavelength range of 260 to 270 nm is used, the output is preferably 10 to 200 mW. If the output range is within the above range, workability is good and the desired diameter of the hole can be achieved while avoiding excessive irradiation.
また、レーザー光線の走査速度は、1~100mm/sが好ましい。レーザー光線の移動速度が前記範囲内にあると、作業性が良く、また、過剰な照射を避けつつも、所望の径の穿孔を達成できる。 The scanning speed of the laser beam is preferably 1 to 100 mm/s. If the moving speed of the laser beam is within this range, workability is good and it is possible to achieve perforation of the desired diameter while avoiding excessive irradiation.
細孔の穿孔は、樹脂を含む成分から成形体を得た後に、または樹脂を含む成分からの成形体の作製と同時に行ってもよい。細孔を穿孔した成形体を培養部材としてそのまま用いてもよいし、その成形体を延伸してから用いてもよい。好ましくは、樹脂を含む成分からフィルムまたはシートを成形し、そのフィルムまたはシートに細孔を穿孔した後、その穿孔済みフィルムまたはシートを成形して所望の形状を有する培養部材にする。あるいは、好ましくは、樹脂を含む成分から成形して所望の形状を有する成形体を作製した後に、細孔を穿孔する。 The perforation of the pores may be performed after obtaining a molded body from the resin-containing component, or simultaneously with the preparation of the molded body from the resin-containing component. The molded body with perforated pores may be used as a culture member as is, or may be stretched before use. Preferably, a film or sheet is molded from the resin-containing component, pores are perforated in the film or sheet, and the perforated film or sheet is molded into a culture member having a desired shape. Alternatively, preferably, the pores are perforated after a molded body having a desired shape is prepared by molding the resin-containing component.
細孔の穿孔を、樹脂を含む成分からの成形体の作製と同時に行う方法としては、例えば、樹脂の有機溶媒溶液を基板上にキャストし、該有機溶媒を蒸散させるとともに該キャスト液表面で結露を起こさせ、該結露により生じた微小水滴を蒸発させることにより細孔を有する培養部材を得る方法、および、メルトブローン法により、溶融した熱可塑性樹脂を紡糸口金から加熱ガスとともに吐出し、前記加熱ガスにより前記熱可塑性樹脂を延伸して、繊維状樹脂とし、細孔を有する培養部材を得る方法が挙げられる。 Examples of methods for perforating pores simultaneously with the production of a molded body from a resin-containing component include a method in which an organic solvent solution of a resin is cast onto a substrate, the organic solvent is evaporated while condensation occurs on the surface of the casting liquid, and the microdroplets resulting from the condensation are evaporated to obtain a culture member having pores, and a method in which a molten thermoplastic resin is discharged from a spinneret together with heated gas by the melt-blown method, and the thermoplastic resin is stretched by the heated gas to form a fibrous resin, thereby obtaining a culture member having pores.
<細胞、組織、または器官>
本発明における細胞は、特に限定されず、動物細胞の場合には浮遊性細胞であってもよく、接着性細胞であってもよく、例えば、線維芽細胞、間葉系幹細胞、造血幹細胞、神経幹細胞、神経細胞、角膜上皮細胞、口腔粘膜上細胞、網膜色素上細胞、歯根膜幹細胞、筋繊維芽細胞、心筋細胞、肝細胞、脾内分泌細胞、皮膚角化細胞、皮膚繊維芽細胞、皮下脂肪由来前駆細胞、腎臓細胞、底部毛根鞘細胞、鼻粘膜上皮細胞、血管内皮前駆細胞、血管内皮細胞、血管平滑筋細胞、骨芽細胞、軟骨細胞、骨格筋細胞、不死化細胞、がん細胞、角化細胞、胚性幹細胞(ES細胞)、EBV形質転換B細胞、人工多能性幹細胞(iPS細胞)などが例示される。初代培養細胞あるいは株化継代された細胞のいずれであってもよい。皮膚、腎臓、肝臓、脳、神経組織、心筋組織、骨格筋組織、がん幹細胞などは酸素要求性が高く、それらを構成する細胞もまた、酸素要求性の高い細胞であることから、本発明における細胞は皮膚、腎臓、肝臓、脳、神経組織、心筋組織、または骨格筋組織を構成する細胞、もしくはがん幹細胞であることが好ましい。細胞、組織、または器官としては、肝細胞、腎細胞、心筋細胞、神経細胞、またはがん幹細胞であることが好ましく、肝細胞であることがより好ましい。
<Cells, tissues, or organs>
The cells in the present invention are not particularly limited, and in the case of animal cells, they may be floating cells or adhesive cells, and examples thereof include fibroblasts, mesenchymal stem cells, hematopoietic stem cells, neural stem cells, nerve cells, corneal epithelial cells, oral mucosa cells, retinal pigment cells, periodontal ligament stem cells, myofibroblasts, cardiac muscle cells, hepatocytes, splenic endocrine cells, skin keratinocytes, skin fibroblasts, subcutaneous fat-derived precursor cells, kidney cells, bottom root sheath cells, nasal mucosa epithelial cells, vascular endothelial precursor cells, vascular endothelial cells, vascular smooth muscle cells, osteoblasts, chondrocytes, skeletal muscle cells, immortalized cells, cancer cells, keratinocytes, embryonic stem cells (ES cells), EBV-transformed B cells, and induced pluripotent stem cells (iPS cells). They may be either primary cultured cells or established, passaged cells. Since the skin, kidney, liver, brain, nerve tissue, cardiac tissue, skeletal muscle tissue, cancer stem cells, etc. have a high oxygen requirement and the cells that compose them also have a high oxygen requirement, the cells in the present invention are preferably cells that compose the skin, kidney, liver, brain, nerve tissue, cardiac tissue, or skeletal muscle tissue, or cancer stem cells. As the cells, tissues, or organs, hepatocytes, renal cells, cardiac muscle cells, nerve cells, or cancer stem cells are preferred, and hepatocytes are more preferred.
本発明における組織とは、類似の細胞が集って同じような働きをするものの意味である。前記組織は、特に限定されず、例えば、上皮組織、結合組織、筋組織、神経組織等が挙げられる。酸素要求性が高いことから、前記組織は、肝小葉、心筋組織、神経組織、または骨格筋組織であることが好ましく、肝小葉がさらに好ましい。 In the present invention, tissue means a collection of similar cells that perform a similar function. The tissue is not particularly limited, and examples include epithelial tissue, connective tissue, muscle tissue, and nerve tissue. Because of their high oxygen requirement, the tissue is preferably hepatic lobule, cardiac muscle tissue, nerve tissue, or skeletal muscle tissue, and more preferably hepatic lobule.
本発明における器官とは、前記組織が集って目的をもった共同の仕事をするものの意味である。前記器官は、特に限定されず、例えば肺、心臓、肝臓、腎臓、脾臓、膵臓、胆嚢、食道、胃、皮膚、脳などである。酸素要求性が高いことから、前記器官は、皮膚、腎臓、肝臓、脳であることが好ましく、肝臓がさらに好ましい。 In the present invention, an organ refers to a group of tissues that work together to accomplish a common purpose. The organ is not particularly limited, and may be, for example, the lungs, heart, liver, kidneys, spleen, pancreas, gallbladder, esophagus, stomach, skin, or brain. Because of their high oxygen demand, the organ is preferably the skin, kidneys, liver, or brain, and more preferably the liver.
培養器具の培養面での培養に適することから、細胞等は細胞であることが好ましい。本発明において、細胞等は、好気性であると好ましく、嫌気性のものを含まないことがより好ましい。細胞等の由来は、特に限定されず、動物、植物、菌、原生生物、細菌などあらゆる生物であってよいが、動物、または植物が好ましく、動物がさらに好ましく、特に哺乳動物が好ましい。本発明における培養器具は、酸素供給性が好適であり、細胞接着性も保持しているので、細胞等は付着性のものであることが好ましく、付着性細胞であるとさらに好ましい。 The cells, etc. are preferably cells, since they are suitable for culturing on the culture surface of the culture tool. In the present invention, the cells, etc. are preferably aerobic, and more preferably do not include anaerobic ones. The origin of the cells, etc. is not particularly limited, and may be any organism, such as an animal, a plant, a fungus, a protozoan, or a bacterium, but animals or plants are preferred, animals are more preferred, and mammals are particularly preferred. The culture tool in the present invention has suitable oxygen supply properties and also retains cell adhesive properties, so the cells, etc. are preferably adherent, and more preferably adherent cells.
<肝細胞>
本発明における肝細胞は、肝実質細胞(Hepatocyte)を始め、肝臓中の細胞であればいかなる細胞であってもよく、具体的には血管内皮細胞、血管平滑筋細胞、脂肪細胞、血球細胞、肝単核細胞、肝マクロファージ(クッパー細胞を含む)、肝星状細胞、肝内胆管上皮細胞、胚嚢線維芽細胞等を含む。前記肝細胞は、例えば20%以上、30%以上、40%以上または50%以上の肝実質細胞が含まれる細胞集団である。
<Hepatocytes>
The hepatocytes in the present invention may be any cells present in the liver, including hepatocytes, and specifically include vascular endothelial cells, vascular smooth muscle cells, adipocytes, blood cells, hepatic mononuclear cells, hepatic macrophages (including Kupffer cells), hepatic stellate cells, intrahepatic bile duct epithelial cells, embryonic sac fibroblasts, etc. The hepatocytes are a cell population containing, for example, 20% or more, 30% or more, 40% or more, or 50% or more of hepatic parenchymal cells.
前記肝細胞は、初代培養細胞でも、株化継代細胞でもよいが、肝細胞としては初代培養細胞を用いるのが好ましい。株化継代細胞の種類は特に制限されないが、例えば、SSP-25、RBE、HepG2、TGBC50TKB、HuH-6、HuH-7、ETK-1、Het-1A、PLC/PRF/5、Hep3B、SK-HEP-1、C3A、THLE-2、THLE-3、HepG2/2.2.1、SNU-398、SNU-449、SNU-182、SNU-475、SNU-387、SNU-423、FL62891、DMS153等が挙げられる。 The hepatocytes may be primary cultured cells or established subcultured cells, but it is preferable to use primary cultured cells as the hepatocytes. The type of established subcultured cells is not particularly limited, but examples include SSP-25, RBE, HepG2, TGBC50TKB, HuH-6, HuH-7, ETK-1, Het-1A, PLC/PRF/5, Hep3B, SK-HEP-1, C3A, THLE-2, THLE-3, HepG2/2.2.1, SNU-398, SNU-449, SNU-182, SNU-475, SNU-387, SNU-423, FL62891, DMS153, etc.
前記肝細胞の由来は、いずれの哺乳動物であってもよいが、特に、ヒト、ウシ、イヌ、ネコ、ブタ、ミニブタ、ウサギ、ハムスター、ラット、またはマウスの細胞が好ましく、ヒト、ラット、マウス、またはウシの細胞がより好ましい。 The hepatocytes may be derived from any mammal, but are preferably derived from humans, cows, dogs, cats, pigs, minipigs, rabbits, hamsters, rats, or mice, and more preferably from humans, rats, mice, or cows.
前記肝細胞は、肝細胞以外の他の細胞種が含まれる細胞集団であってもよく、例えば20%以上、30%以上、40%以上または50%以上の肝細胞が含まれる細胞集団である。 The hepatocytes may be a cell population that includes cell types other than hepatocytes, for example, a cell population that includes 20% or more, 30% or more, 40% or more, or 50% or more of hepatocytes.
〈培養〉
本発明において、培養とは、細胞等を増殖、維持させることだけでなく、細胞等の播種、継代、分化誘導、自己組織化誘導等のプロセスも含む広い意味で用いる。培養に用いる培地等は制限されず、細胞等の特性に応じた培地を選択すればよい。
<culture>
In the present invention, the term "culture" is used in a broad sense to include not only proliferation and maintenance of cells, etc., but also processes such as seeding, subculturing, differentiation induction, and self-organization induction of cells, etc. There are no limitations on the medium, etc. used for culture, and a medium may be selected according to the characteristics of the cells, etc.
〈細胞の培養〉
細胞の培養は、2次元(細胞が自発的に重層化する場合を含む)培養でも、3次元培養でもよい。本発明の培養部材は、酸素供給性が培養に好適であるため、2次元培養だけでなく、立体的に細胞が積み重なっている3次元培養においても、細胞に充分に酸素を供給することができ、細胞が増殖、分化し、さらに細胞の高度な自己組織化現象も起きやすい。
<Cell Culture>
The culture of cells may be two-dimensional (including the case where cells spontaneously form layers) or three-dimensional. The culture member of the present invention has suitable oxygen supplying properties for culture, so that not only two-dimensional culture but also three-dimensional culture in which cells are stacked three-dimensionally can be sufficiently supplied with oxygen, and the cells can proliferate and differentiate, and furthermore, a highly advanced self-organization phenomenon of the cells can easily occur.
3次元培養とは、意図的に細胞を立体的に培養することであり、足場材の中で細胞を培養するScaffold型と、塊(スフェロイド)として浮遊状態で細胞を培養するScaffold-free型のどちらであってもよいが、Scaffold型が好ましい。Scaffold型の場合、細胞を効率よく培養できることから足場材としては、MatrigelTM、コラーゲンゲル、ラミニン、アルギン酸ヒドロゲル、ビトリゲルが好ましい。 Three-dimensional culture is the intentional cultivation of cells in a three-dimensional space, and may be either a scaffold type in which cells are cultivated in a scaffold material, or a scaffold-free type in which cells are cultivated in a suspended state as a mass (spheroid), but the scaffold type is preferred. In the case of the scaffold type, Matrigel ™ , collagen gel, laminin, alginate hydrogel, and vitrigel are preferred as scaffold materials because they allow efficient cultivation of cells.
培養に用いる培地等は制限されないが、細胞を効率的に培養するため、細胞は、血清(例えば、ウシ胎児血清)の存在下で培養することが好ましい。 There are no limitations on the medium used for culturing, but in order to culture the cells efficiently, it is preferable to culture the cells in the presence of serum (e.g., fetal bovine serum).
本発明の培養部材を培養に用いる際、言い換えると、本発明の培養器具を用いて、培養を行う際の、細胞培養密度としては、好ましくは0.1×105cells/cm2~10.0×105cells/cm2であり、より好ましくは0.5×105cells/cm2~5.0×105cells/cm2であり、さらに好ましくは1.0×105cells/cm2~4.0×105cells/cm2である。
上記の範囲であると、細胞培養密度が上記範囲外の場合と比べて、薬物代謝活性がより亢進されるため好ましい。
本発明の培養部材は、酸素供給性に優れるため、細胞培養密度が高い場合であっても、好適に培養することができる。一般に、生体の細胞密度は、2.5×105cells/cm2程度だといわれているが、本発明の培養部材は、生体と同程度の細胞培養密度で、培養を行うことが可能であるため、in vitroにて、in vivoにより近い状態で培養を行うことができるため好ましい。
When using the culture member of the present invention for culture, in other words, when culturing using the culture apparatus of the present invention, the cell culture density is preferably 0.1 x 10 5 cells/cm 2 to 10.0 x 10 5 cells/cm 2 , more preferably 0.5 x 10 5 cells/cm 2 to 5.0 x 10 5 cells/cm 2 , and even more preferably 1.0 x 10 5 cells/cm 2 to 4.0 x 10 5 cells/cm 2 .
The above range is preferable because the drug metabolic activity is enhanced more than when the cell culture density is outside the above range.
The culture member of the present invention has excellent oxygen supplying properties, and therefore can be used for suitable culture even when the cell culture density is high. Generally, the cell density in a living body is said to be about 2.5×10 5 cells/cm 2 , but the culture member of the present invention is preferable because it can be used for culture at a cell culture density similar to that of a living body, and therefore it can be used for culture in vitro under conditions closer to those in vivo.
〈培養器具〉
本発明において、培養器具とは、細胞等の培養に用いる器具全てを意味する。前記培養器具は、少なくともその一部が前記培養部材から構成される。前記培養器具は、その全部が前記培養部材から構成されてもよいし、その一部のみが前記培養部材から構成されてもよい。前記培養器具の一部のみが前記培養部材から構成される場合、少なくも細胞等を培養する培養面が、本発明の培養部材により構成される。
<Culture equipment>
In the present invention, a culture instrument means any instrument used for culturing cells, etc. At least a part of the culture instrument is composed of the culture member. The culture instrument may be entirely composed of the culture member, or only a part of the culture instrument may be composed of the culture member. When only a part of the culture instrument is composed of the culture member, at least the culture surface for culturing cells, etc. is composed of the culture member of the present invention.
前記培養器具は通常、インキュベーター、大量培養装置、または灌流培養装置などの装置内で用いる。 The culture device is typically used in an apparatus such as an incubator, mass culture apparatus, or perfusion culture apparatus.
前記培養器具としては、公知の各種の培養器具を用いることができ、形状や大きさは特に制限されない。前記培養器具としては、例えば、ディッシュ、フラスコ、プレート、ボトル、バッグ、チューブ等の培養容器の他、インサート、カップ、中敷き、スライド等が挙げられ、好ましくは培養容器である。 As the culture tool, various known culture tools can be used, and the shape and size are not particularly limited. Examples of the culture tool include culture vessels such as dishes, flasks, plates, bottles, bags, and tubes, as well as inserts, cups, insoles, and slides, and the like, preferably culture vessels.
前記培養器具は、少なくとも1つのウェルを有する培養器具であることが好ましく、少なくとも1つのウェルを有する培養容器であることがより好ましく、少なくとも1つのウェルを有するプレートであることがさらに好ましく、6ウェル、12ウェル、24ウェル、48ウェル、96ウェル、384ウェル、1536ウェル等のウェルを有するプレートであることがさらに好ましい。一般にウェルのようなくぼみ形状を底面に有する培養器具は、底面の複雑な形状を安定させるために底面を厚くする必要があり、細胞等への酸素供給が充分に行われ難い。本発明の培養部材を用いると、1ウェル、6ウェル、12ウェル、24ウェル、48ウェル、96ウェル、384ウェル、1536ウェル等のウェルを有するプレートであっても、形状が安定しており、細胞等への酸素供給も充分である。 The culture device is preferably a culture device having at least one well, more preferably a culture vessel having at least one well, even more preferably a plate having at least one well, and even more preferably a plate having wells of 6 wells, 12 wells, 24 wells, 48 wells, 96 wells, 384 wells, 1536 wells, etc. In general, a culture device having a well-like recessed shape on the bottom surface needs to have a thick bottom surface to stabilize the complex shape of the bottom surface, and it is difficult to sufficiently supply oxygen to cells, etc. When the culture member of the present invention is used, even a plate having wells of 1 well, 6 wells, 12 wells, 24 wells, 48 wells, 96 wells, 384 wells, 1536 wells, etc. has a stable shape and sufficient oxygen supply to cells, etc.
前記培養器具は、培地を保持あるいは貯留するため、底面を培養面とする器具であることが好ましい。前記培養器具が、ディッシュ、フラスコ、インサート、またはプレートの場合、底面が培養面であるので、本発明の培養部材は、これらの底面、側面、上面のうち、少なくとも底面の一部または全部を構成することが好ましい。少なくとも底面(培養面)が本発明の培養部材で構成されていると、前記培養部材を介して培地中に酸素をより効率的に供給でき、培地中にある細胞等をより効率的に増殖させることができる。また、細胞の機能を保持したまま、より高密度で培養することができる。 The culture tool is preferably a tool with a bottom surface as a culture surface in order to hold or store the culture medium. When the culture tool is a dish, flask, insert, or plate, the bottom surface is the culture surface, and therefore the culture member of the present invention preferably constitutes at least a part or all of the bottom surface, side surface, and top surface. When at least the bottom surface (culture surface) is constituted by the culture member of the present invention, oxygen can be more efficiently supplied to the culture medium via the culture member, and cells, etc. in the culture medium can be more efficiently grown. In addition, cells can be cultured at a higher density while retaining their functions.
前記培養器具の底面の形状は特に制限されず、平底、丸底(U底)、平底(F底)、円錐底(V底)、平底+カーブエッジ等が挙げられる。丸底(U底)、平底(F底)、円錐底(V底)、平底+カーブエッジ等に加工する場合には、一般の射出成形やプレス成形で一度に加工してもよいし、フィルムまたはシートを作成しておき、真空成形や圧空成形などで2次加工を行い作成することも可能である。底面の形状は培養の目的に応じて選択されるが、細胞等を2次元培養する際には、平底であることが通常は望ましく、3次元培養する際には丸底(U底)または円錐底(V底)であることが通常は望ましい。 The shape of the bottom of the culture device is not particularly limited, and examples thereof include a flat bottom, a round bottom (U bottom), a flat bottom (F bottom), a conical bottom (V bottom), a flat bottom with a curved edge, etc. When processing into a round bottom (U bottom), a flat bottom (F bottom), a conical bottom (V bottom), a flat bottom with a curved edge, etc., it may be processed at once by general injection molding or press molding, or it is also possible to create a film or sheet first and then perform secondary processing such as vacuum forming or pressure forming to create the bottom. The shape of the bottom is selected depending on the purpose of the culture, but when cells, etc. are cultured two-dimensionally, a flat bottom is usually desirable, and when cells, etc. are cultured three-dimensionally, a round bottom (U bottom) or a conical bottom (V bottom) is usually desirable.
培養器具の前記培養部材以外の部分は、前記培養部材以外の材料で構成してもよい。前記培養部材以外の材料は特に制限されず、公知の材料を用いることができる。かかる材料としては、例えば、ポリジメチルシロキサン(PDMS)、熱硬化性樹脂、環状オレフィンポリマー、環状オレフィンコポリマー、ガラス等が挙げられる。 The portions of the culture instrument other than the culture member may be made of a material other than the culture member. The material other than the culture member is not particularly limited, and known materials can be used. Examples of such materials include polydimethylsiloxane (PDMS), thermosetting resin, cyclic olefin polymer, cyclic olefin copolymer, glass, etc.
前記培養器具は、その培養面上に天然高分子材料、合成高分子材料、または無機材料をコーティングされた培養器具であってもよい。 The culture device may be a culture device whose culture surface is coated with a natural polymer material, a synthetic polymer material, or an inorganic material.
前記コーティングされた培養器具は、例えば、培養器具を天然高分子材料、合成高分子材料、または無機材料で公知の方法によりコーティングすることにより得てもよいし、既にコーティングされた前記培養部材を培養器具の少なくとも培養面に用いることにより得てもよい。 The coated culture instrument may be obtained, for example, by coating the culture instrument with a natural polymer material, a synthetic polymer material, or an inorganic material by a known method, or by using an already coated culture member on at least the culture surface of the culture instrument.
前記コーティングされた培養器具は、細胞等の接着性、増殖性がより優れる。これは、培養面にコーティングされている天然高分子材料、合成高分子材料、または無機材料が、細胞等の足場となるためと考えられる。したがって、付着性の細胞等を培養する際には、培養部材、または培養器具に天然高分子材料、合成高分子材料、または無機材料をコーティングし、培養器具として用いることが好ましい一形態である。 The coated culture device has better adhesion and proliferation properties for cells, etc. This is thought to be because the natural polymer material, synthetic polymer material, or inorganic material coated on the culture surface serves as a scaffold for cells, etc. Therefore, when culturing adherent cells, etc., it is a preferred embodiment to coat the culture member or culture device with a natural polymer material, synthetic polymer material, or inorganic material and use it as a culture device.
前記天然高分子材料、合成高分子材料、または無機材料は特に制限されないが、天然高分子材料として、コラーゲン、ゼラチン、アルギン酸、ヒアルロン酸やコンドロイチン硫酸等のグリコサミノグリカン、フィブロネクチン、ラミニン、フィブリノーゲン、オステオポンチン、テネイシン、ビトロネクチン、トロンボスボジン、アガロース、エラスチン、ケラチン、キトサン、フィブリン、フィブロイン、糖類、合成高分子材料として、ポリグルコース酸、ポリ乳酸、ポリエチレングリコール、ポリカプロラクトン、合成ペプチド類、合成タンパク質類、合成高分子材料としてポリエチレングリコール、ポリヒドロキシエチルメタクリラート、ポリエチレンイミン、無機材料として、β-リン酸三カルシウム、炭酸カルシウムなどが挙げられる。 The natural polymeric materials, synthetic polymeric materials, and inorganic materials are not particularly limited, but examples of natural polymeric materials include collagen, gelatin, alginic acid, glycosaminoglycans such as hyaluronic acid and chondroitin sulfate, fibronectin, laminin, fibrinogen, osteopontin, tenascin, vitronectin, thrombospondin, agarose, elastin, keratin, chitosan, fibrin, fibroin, and sugars; synthetic polymeric materials include polyglucose acid, polylactic acid, polyethylene glycol, polycaprolactone, synthetic peptides, and synthetic proteins; synthetic polymeric materials include polyethylene glycol, polyhydroxyethyl methacrylate, and polyethyleneimine; and inorganic materials include β-tricalcium phosphate and calcium carbonate.
また、前記天然高分子材料、合成高分子材料、または無機材料としては、従来の細胞外マトリックス成分等のハイドロゲルをガラス化した後に再水和して得られるビトリゲルなども挙げられる。例えば、細胞外マトリックス成分の一つであるコラーゲンから作製された高密度のコラーゲン繊維網で構成されるコラーゲンビトリゲルも挙げられる。 The natural polymeric material, synthetic polymeric material, or inorganic material may also include a vitrigel obtained by vitrifying a hydrogel such as a conventional extracellular matrix component and then rehydrating it. For example, a collagen vitrigel made of a high-density collagen fiber network made from collagen, which is one of the extracellular matrix components, may also be used.
細胞の接着性や細胞の増殖性を向上させる、細胞の機能をより長期に維持させる、などの観点から、コラーゲン、ゼラチン、ラミニン、ポリリジン等のタンパク質、またはペプチドによるコーティングが好ましく、コラーゲンまたはポリリジンによるコーティング処理がより好ましい。これらのコーティングは、1種単独でもよいし、2種以上を組み合わせて行ってもよい。 From the viewpoint of improving cell adhesion and proliferation, and maintaining cell function for a longer period of time, coating with proteins or peptides such as collagen, gelatin, laminin, and polylysine is preferred, and coating with collagen or polylysine is more preferred. These coatings may be used alone or in combination of two or more types.
本発明の培養器具は、コンタミネーション防止のために、消毒・滅菌処理を施してもよい。消毒・滅菌処理の方法としては、特に制限されず、流通蒸気法、煮沸法、間歇法、紫外線法等の物理的消毒法、オゾン等の気体、エタノール等の消毒薬を用いる化学的消毒法;高圧蒸気法、乾熱法等の加熱滅菌法;ガンマ線法、高周波法等の照射滅菌法;酸化エチレンガス法、過酸化水素ガスプラズマ法等のガス滅菌法等が挙げられる。中でも操作が簡便で、充分に滅菌が行えることから、エタノール消毒法、高圧蒸気滅菌法、ガンマ線滅菌法、または酸化エチレンガス滅菌法が好ましい。これらの消毒・滅菌処理は、1種単独で行ってもよいし、2種以上を組み合わせて行ってもよい。 The culture tool of the present invention may be disinfected or sterilized to prevent contamination. The method of disinfection or sterilization is not particularly limited, and examples thereof include physical disinfection methods such as steam circulation, boiling, intermittent irradiation, and ultraviolet light; chemical disinfection methods using gases such as ozone and disinfectants such as ethanol; heat sterilization methods such as high-pressure steam and dry heat; irradiation sterilization methods such as gamma ray and high-frequency; and gas sterilization methods such as ethylene oxide gas and hydrogen peroxide gas plasma. Among these, ethanol disinfection, high-pressure steam sterilization, gamma ray sterilization, and ethylene oxide gas sterilization are preferred because they are easy to operate and can perform sufficient sterilization. These disinfection and sterilization methods may be performed alone or in combination of two or more.
本発明の培養器具の製造方法は、特に制限されず、培養器具の全部が前記培養部材から構成される場合には、培養部材の製造方法と同様の方法で製造することができる。培養器具の一部が前記培養部材で形成される場合には、培養部材と、その他の部材とを、適宜接合することにより培養器具を得ることができる。接合する方法としては特に制限はなく、培養部材と、その他の部材とを一体で形成してもよく、接着剤や粘着剤を介して密着させてもよい。 The method for manufacturing the culture instrument of the present invention is not particularly limited, and when the entire culture instrument is composed of the culture member, it can be manufactured by the same method as the method for manufacturing the culture member. When only a part of the culture instrument is formed of the culture member, the culture instrument can be obtained by appropriately joining the culture member and other members. There is no particular limit to the joining method, and the culture member and other members may be formed integrally, or may be adhered to each other via an adhesive or pressure sensitive adhesive.
本発明の培養器具は、細胞培養器具であることが好ましく、肝細胞培養器具であるとより好ましい。 The culture instrument of the present invention is preferably a cell culture instrument, and more preferably a liver cell culture instrument.
〈培養方法〉
本発明の細胞等の培養方法は、細胞、組織、または器官をその培養面上で培養する培養部材であり、前記培養部材は樹脂を含み、前記培養面は少なくとも1つの細孔を有する、培養部材の培養面に、細胞、組織または器官を接触させる工程;および
前記培養面に接触した細胞、組織または器官に酸素を供給する工程;を含む細胞、組織、または器官の培養方法である。
培養部材の培養面に、細胞等を接触させる方法は、培養部材の培養面に細胞等を接触させることができれば特に制限されず、例えば、培養部材または培養器具の培養面に細胞等を播種することが挙げられる。
培養面に接触した細胞等に酸素を供給する方法は、培養面に接触した細胞等に酸素を供給できれば特に制限されず、例えば、培養部材または培養器具を入れた培養インキュベーターに酸素を供給し、培養部材を介して細胞等に酸素を供給することが挙げられる。
前記樹脂は、熱可塑性樹脂であり、前記細孔の平均孔径が0.1~100μmであり、前記細孔の単位面積当たりの個数が、0.01~250個/cm2であることが好ましい。
前記細胞等の培養方法は、細胞の培養方法であることが好ましく、肝細胞の培養方法であるとさらに好ましい。
Cultivation Method
The method for culturing cells or the like of the present invention is a culture component for culturing cells, tissues, or organs on its culture surface, the culture component containing a resin, and the culture surface having at least one pore, and is a method for culturing cells, tissues, or organs, the method comprising: a step of contacting the cells, tissues, or organs with the culture surface of the culture component; and a step of supplying oxygen to the cells, tissues, or organs in contact with the culture surface.
The method of contacting cells, etc. with the culture surface of the culture component is not particularly limited as long as it is possible to contact the cells, etc. with the culture surface of the culture component, and examples thereof include seeding the cells, etc. on the culture surface of the culture component or culture instrument.
The method of supplying oxygen to cells, etc. in contact with the culture surface is not particularly limited as long as it is possible to supply oxygen to cells, etc. in contact with the culture surface. For example, oxygen may be supplied to a culture incubator containing a culture component or culture equipment, and oxygen may be supplied to the cells, etc. via the culture component.
It is preferable that the resin is a thermoplastic resin, the average pore size of the pores is 0.1 to 100 μm, and the number of the pores per unit area is 0.01 to 250 pores/cm 2 .
The method for culturing cells or the like is preferably a method for culturing cells, and more preferably a method for culturing hepatocytes.
次に本発明について実施例を示してさらに詳細に説明するが、本発明はこれらによって限定されるものではない。
なお、実施例におけるコラーゲンコート溶液の調整方法、細胞種と培地の調製方法、酸素透過度の測定方法、撓みの有無の評価方法、細胞接着性の評価方法、培地中の酸素濃度の測定方法、代謝活性値の測定方法を以下に記載した。
The present invention will now be described in more detail with reference to examples, but the present invention is not limited to these.
The methods for adjusting the collagen coating solution, the cell type and culture medium preparation, the method for measuring oxygen permeability, the method for evaluating the presence or absence of bending, the method for evaluating cell adhesion, the method for measuring the oxygen concentration in the culture medium, and the method for measuring metabolic activity are described below.
[コラーゲンコート溶液の調整]
0.1Mの塩酸溶液(容量分析用、富士フイルム和光純薬)を注射用水(日本薬局方、大塚製薬)で100倍希釈し、0.001Mの塩酸溶液を調製してろ過滅菌をした。3mg/mLのコラーゲン溶液(セルマトリックスTypeI-P、ブタ腱由来、新田ゼラチン)を0.001Mの塩酸溶液で6倍希釈し、0.5mg/mLのコラーゲン溶液を調製した。
[Preparation of collagen coating solution]
A 0.1 M hydrochloric acid solution (for volumetric analysis, Fujifilm Wako Pure Chemical Industries, Ltd.) was diluted 100-fold with water for injection (Japanese Pharmacopoeia, Otsuka Pharmaceutical Co., Ltd.) to prepare a 0.001 M hydrochloric acid solution, which was then sterilized by filtration. A 3 mg/mL collagen solution (Cell Matrix Type I-P, derived from porcine tendon, Nitta Gelatin) was diluted 6-fold with a 0.001 M hydrochloric acid solution to prepare a 0.5 mg/mL collagen solution.
[細胞種と培地の調製]
ラット初代凍結肝細胞を含む細胞懸濁液を入れた遠沈管(50ml)に培地を加えた。培地は、ウシ胎児血清(Fetal Bovine Serum、FBS、富士フイルム和光純薬)を1.5mL、注射用水(扶桑薬品工業)で3.0g/mLに希釈したL-プロリン(培養用、富士フイルム和光純薬)溶液を0.15mL、エタノール(分子生物学用、富士フィルム和光純薬)で1×10-3Mに希釈したデキサメタゾン(生化学用、富士フイルム和光純薬)溶液を1.5μL、エタノールで36mMに希釈したハイドロコルチゾン(培養用、富士フイルム和光純薬)溶液を21μL、注射用水で1.0mg/mLに希釈したBSA溶液を用いて、さらに20μg/mLに希釈した上皮成長因子(Epidermal growth factor、EGF、細胞生物学用、富士フイルム和光純薬)溶液を15μL、インスリン溶液(10mg/mL in HEPESS、SIGMA)を8.7μL、ペニシリン-ストレプトマイシン溶液(5000units/mLペニシリン、5000μg/mLストレプトマイシン含有、培養用、富士フイルム和光純薬)を0.3mL、D-MEM培地(4500mg/mL D-グルコース、584mg/mL L-グルタミン、15mg/mLフェノールレッド、110mg/mLピルビン酸ナトリウム、3700mg/mL炭酸水素ナトリウム含有、培養用、富士フイルム和光純薬)を13mL加えて調整した。細胞密度の調整は、ラット初代凍結肝細胞を含む細胞懸濁液の細胞数を調整する方法で実施し、特に断りのない限りは4.0×105cells/cm2の細胞密度で、実施例9および比較例1、3、5では1.0×105cells/cm2の細胞密度で培養した。
[Cell types and medium preparation]
A medium was added to a centrifuge tube (50 ml) containing a cell suspension containing rat primary frozen hepatocytes. The medium was composed of 1.5 mL of fetal bovine serum (FBS, Fujifilm Wako Pure Chemical Industries), 0.15 mL of L-proline (for culture, Fujifilm Wako Pure Chemical Industries) solution diluted to 3.0 g/mL with water for injection (Fuso Pharmaceutical Industries), 1.5 μL of dexamethasone (for biochemistry, Fujifilm Wako Pure Chemical Industries) solution diluted to 1 × 10 -3 M with ethanol (for molecular biology, Fujifilm Wako Pure Chemical Industries), 21 μL of hydrocortisone (for culture, Fujifilm Wako Pure Chemical Industries) solution diluted to 36 mM with ethanol, and epidermal growth factor (EGF) diluted to 20 μg/mL using BSA solution diluted to 1.0 mg/mL with water for injection. factor, EGF, for cell biology, Fujifilm Wako Pure Chemical Industries) solution 15 μL, insulin solution (10 mg/mL in HEPESS, SIGMA) 8.7 μL, penicillin-streptomycin solution (containing 5000 units/mL penicillin and 5000 μg/mL streptomycin, for culture, Fujifilm Wako Pure Chemical Industries) 0.3 mL, and D-MEM medium (containing 4500 mg/mL D-glucose, 584 mg/mL L-glutamine, 15 mg/mL phenol red, 110 mg/mL sodium pyruvate, and 3700 mg/mL sodium bicarbonate, for culture, Fujifilm Wako Pure Chemical Industries) 13 mL were added to adjust the medium. The cell density was adjusted by adjusting the cell number of a cell suspension containing frozen rat primary hepatocytes. Unless otherwise specified, the cells were cultured at a cell density of 4.0 x 105 cells/ cm2 , and in Example 9 and Comparative Examples 1, 3, and 5, the cells were cultured at a cell density of 1.0 x 105 cells/ cm2 .
[酸素透過度の測定]
東洋精機製作所製差圧式ガス透過率測定装置MT-C3を用いて温度23℃、湿度0%RHの環境下にて、細孔を穿孔する前のフィルムの酸素透過度を測定した。測定部径は70mm(透過面積は38.46cm2)とした。予めサンプルにアルミニウムマスクを施し、実透過面積を5.0cm2とした。
[Oxygen permeability measurement]
The oxygen transmission rate of the film before perforation was measured at a temperature of 23°C and a humidity of 0% RH using a differential pressure gas transmission rate measuring device MT-C3 manufactured by Toyo Seiki Seisakusho Co., Ltd. The diameter of the measurement area was 70 mm (transmission area: 38.46 cm2 ). An aluminum mask was applied to the sample in advance, and the actual transmission area was set to 5.0 cm2 .
[撓みの有無]
細胞播種の1日後、インキュベーターから培養容器を取り出して、4個の培養容器のそれぞれについて容器底面を横方向から覗き込み、培養環境におけるフィルムの垂れ下がりの有無を観察した。4つの培養容器全てにおいて、容器作製時と比べて変化が無く、フィルムの垂れ下がりは見られない場合を「撓みなし」とし、4つのうち少なくとも1つの培養容器において、培養容器作製時と比べて変化があり、フィルムの垂れ下がりが見られる場合を「撓みあり」と評価した。
[Presence or absence of deflection]
One day after cell seeding, the culture vessels were removed from the incubator, and the bottoms of the four culture vessels were examined from the side to see whether the film sagged in the culture environment. If there was no change in any of the four culture vessels compared to when the vessels were made and no sagging of the film was observed, the result was rated as "no bending," and if there was a change in at least one of the four culture vessels compared to when the vessels were made and sagging of the film was observed, the result was rated as "bending."
[細胞接着性の評価]
細胞播種の1日後、4個の培養容器のそれぞれについて代表的な3ウェルを顕微鏡観察し、細胞が接着しながら増殖している様子を観察した。4つの培養容器全てにおいて、細胞が培養面全体に均一に接着、増殖し、形態を維持している場合を〇とし、4つのうち少なくとも1つの培養容器において、細胞が培養面全体に均一に接着していない、増殖していない、または形態を維持していない場合を×と評価した。
[Evaluation of cell adhesiveness]
One day after cell seeding, three representative wells from each of the four culture vessels were observed under a microscope to observe the state in which the cells were growing while adhering. In all four culture vessels, the cases in which the cells were uniformly adhering and growing over the entire culture surface and maintaining their morphology were evaluated as ◯, and the cases in which the cells were not uniformly adhering over the entire culture surface, not growing, or not maintaining their morphology in at least one of the four culture vessels were evaluated as ×.
[培地中の酸素濃度の測定]
細胞播種の1日後、培養容器の培地を除去した後、新たに培地を0.5mL添加し、蛍光式の酸素センサー(FireSting酸素モニター、株式会社ビー・エー・エス社製)を用いて培地中の酸素分圧(hPa)を測定した。測定は、加湿インキュベーター中で実施し、センサーをジャッキで培養容器底面から80μmの高さに設置し、1時間測定した。測定開始から1時間後の培地中の酸素分圧(hPa)を、1013hPa(大気1気圧)で除して100をかけた値(%)を算出し、培地中の酸素濃度とした。代表的な3ウェルで測定し、平均値を算出した。
[Measurement of oxygen concentration in culture medium]
One day after cell seeding, the medium in the culture vessel was removed, 0.5 mL of new medium was added, and the oxygen partial pressure (hPa) in the medium was measured using a fluorescent oxygen sensor (FireSting oxygen monitor, manufactured by BAS Co., Ltd.). The measurement was performed in a humidified incubator, and the sensor was installed at a height of 80 μm from the bottom of the culture vessel with a jack, and measured for 1 hour. The oxygen partial pressure (hPa) in the medium 1 hour after the start of measurement was divided by 1013 hPa (1 atmospheric pressure) and multiplied by 100 to calculate the value (%), which was used as the oxygen concentration in the medium. Measurements were performed in three representative wells, and the average value was calculated.
[代謝活性値の測定]
細胞播種24時間後の培養容器中の培地を除去した後、培地で希釈したLuciferin-CEEを添加して、さらに3時間培養した。培養後の細胞をLuciferin-CEEを含む培地を同伴して96ウェルプレートに移した後、Luciferin Detection RegentとReconstitution Bufferの混合液を添加して、室温で遮光して1時間反応させた。1時間後、ルミノメーターで発光量(Relative Light Unit、RLU)を測定した。代表的な3ウェルで測定し、平均値を算出した。
[Measurement of metabolic activity value]
After removing the medium from the culture vessel 24 hours after cell seeding, Luciferin-CEE diluted in the medium was added and cultured for another 3 hours. After culture, the cells were transferred to a 96-well plate together with the medium containing Luciferin-CEE, and a mixture of Luciferin Detection Reagent and Reconstitution Buffer was added and reacted for 1 hour at room temperature in the dark. After 1 hour, the luminescence amount (Relative Light Unit, RLU) was measured with a luminometer. Measurements were performed in three representative wells, and the average value was calculated.
蛋白量は、培地で希釈したLuciferin-CEE溶液を除去後、PBS(-)を培地200μL添加した後、セルスクレーパーを用いてエッペンチューブに細胞を回収し、遠心した(4℃、22000×g、10分間)。その後、上澄みを除去し、0.1M水酸化ナトリウム溶液を100μL添加した後、PierceTMBCA Protein Assay Kit(Thermo Fisher Scientific社製)を使用して蛋白量を測定した。波長450nmの吸光度をプレートリーダー(SPECTRA max PLUS384、Molecular Devices社製)で測定した。 The amount of protein was measured by removing the Luciferin-CEE solution diluted with the medium, adding 200 μL of PBS(-) to the medium, and then recovering the cells in an Eppendorf tube using a cell scraper and centrifuging (4°C, 22000 x g, 10 minutes). The supernatant was then removed, 100 μL of 0.1 M sodium hydroxide solution was added, and the amount of protein was measured using Pierce TM BCA Protein Assay Kit (manufactured by Thermo Fisher Scientific). The absorbance at a wavelength of 450 nm was measured using a plate reader (SPECTRA max PLUS384, manufactured by Molecular Devices).
ルミノメーターで得られたLuciferin-CEE溶液の代謝活性量(pmol/L)をP450-GloTM CYP1A1 Assay kit(Promega社製)を使用して測定し、吸光度から得られたタンパク量およびLuciferin-CEE溶液の反応時間で除することにより、代謝活性値(pmol/min/mg protein)を算出した。 The metabolic activity (pmol/L) of the Luciferin-CEE solution obtained with a luminometer was measured using a P450-Glo ™ CYP1A1 Assay kit (Promega), and the metabolic activity value (pmol/min/mg protein) was calculated by dividing the metabolic activity by the protein amount obtained from the absorbance and the reaction time of the Luciferin-CEE solution.
[実施例1]
12cm×8cmサイズの長方形にカットした、厚さ50μmのポリスチレン(以下、PSと記載する)単独重合体の未延伸フィルム(大倉工業株式会社製、商品名:セロマーS-2、酸素透過度3310cm3/(m2×24h×atm))に、UVレーザー加工機(タカノ株式会社製)を用いて、波長266nm、出力50mW、走査速度10mm/sec.、ビーム径5μmの条件にてレーザー加工を実施し、PSフィルムに直径5μmの細孔を24個形成した。細孔の配置については後述する。
デジタルマイクロスコープ(株式会社キーエンス製、VHX-1000)を使用し、穿孔済みフィルムを上方から撮影し、撮影された画像に基づき、孔径を計測した。24個の細孔の孔径の個々の測定値は示さないが、孔径のばらつきは10%以内であった。
穿孔済みフィルムを常圧プラズマ表面処理装置(積水化学工業株式会社製)を用いて、チャンバー内を窒素の気流で満たしプラズマ処理した(処理速度2m/min、出力4.5kW、2往復)。その後、各ウェルの底面が開口しているPS製24ウェル培養プレート枠の底面に、プラズマ処理した穿孔済みフィルムを医療用粘着剤(スリーエム社製)を介して密着させた。1ウェル(直径16mmの円形状、面積約2cm2)当たり、1個の細孔を形成し、細孔密度が0.5個/cm2の24ウェル細胞培養容器を作成した。細孔は、24ウェル培養プレート枠に穿孔済みフィルムを接着させた際に、各ウェルで図1Bに示す通りに配置されるようにあらかじめ設計しておき、穿孔した。具体的には、円形状のウェル底面の内側に沿う円の中心に細孔を1つ配置した。
細胞培養容器を耐ガンマ線袋に梱包して10kGyのガンマ線を照射し滅菌してから培養容器の培養面に、0.5mg/mLのコラーゲン溶液を0.5mL添加した後、余分なコラーゲン溶液を除去した。室温で30~60分間静置した後、ダルベッコPBS(-)で洗浄して、一晩、室温で乾燥させた。同法で作製したコラーゲンコート済みの細胞培養容器を培養容器1とし、同じものを5個作成した。
[Example 1]
A 50 μm thick unstretched film of polystyrene (hereinafter referred to as PS) homopolymer cut into a 12 cm x 8 cm rectangle (manufactured by Okura Kogyo Co., Ltd., product name: Ceromer S-2, oxygen permeability 3310 cm 3 /(m 2 x 24 h x atm)) was laser processed using a UV laser processing machine (manufactured by Takano Co., Ltd.) under conditions of wavelength 266 nm, output 50 mW, scanning speed 10 mm/sec., and beam diameter 5 μm, to form 24 pores with a diameter of 5 μm in the PS film. The arrangement of the pores will be described later.
Using a digital microscope (Keyence Corporation, VHX-1000), the perforated film was photographed from above, and the pore size was measured based on the photographed image. Although the individual measurements of the pore size of the 24 pores are not shown, the variation in pore size was within 10%.
The perforated film was plasma-treated using a normal pressure plasma surface treatment device (manufactured by Sekisui Chemical Co., Ltd.) by filling the chamber with a nitrogen gas flow (treatment speed 2 m/min, output 4.5 kW, 2 round trips). The plasma-treated perforated film was then attached to the bottom of a PS 24-well culture plate frame with an open bottom of each well via a medical adhesive (manufactured by 3M). One pore was formed per well (circular shape with a diameter of 16 mm, area approximately 2 cm 2 ) to create a 24-well cell culture vessel with a pore density of 0.5 pores/cm 2 . The pores were designed in advance to be arranged in each well as shown in FIG. 1B when the perforated film was attached to the 24-well culture plate frame, and perforated. Specifically, one pore was arranged at the center of a circle along the inside of the bottom of the circular well.
The cell culture vessel was packed in a gamma-ray resistant bag and sterilized by irradiating with 10 kGy of gamma rays, after which 0.5 mL of 0.5 mg/mL collagen solution was added to the culture surface of the culture vessel, and then excess collagen solution was removed. After leaving it to stand at room temperature for 30 to 60 minutes, it was washed with Dulbecco's PBS (-) and dried overnight at room temperature. The collagen-coated cell culture vessel produced by the same method was designated as culture vessel 1, and five identical vessels were produced.
次いで、ラット初代凍結肝細胞を含む培地(0.5mL)を5個の培養容器1の培養面それぞれにマイクロピペットで播種し、ポリスチレン製の蓋を被せ、インキュベーターに持ち込んで、37℃、5%CO2下培養を開始した。4個の培養容器で撓みの有無と、細胞接着性を評価した。その後、4個の培養容器1のうち1個を用いて培地中の酸素濃度を測定した。残り3個では代謝活性を測定した。結果を表1に示す。代謝活性値は、3個の容器の結果を平均値として表1に示した。さらに、残り1個の容器は、7日間培養後に細胞接着性を評価した。結果を表1に示す。図2に細胞播種1日後の細胞を位相差顕微鏡で観察した結果を示す。 Next, the culture medium (0.5 mL) containing rat primary frozen hepatocytes was seeded on each of the culture surfaces of the five culture vessels 1 with a micropipette, covered with a polystyrene lid, and brought into an incubator to start culturing at 37°C and 5% CO2 . The presence or absence of bending and cell adhesion were evaluated in four culture vessels. Then, the oxygen concentration in the culture medium was measured using one of the four culture vessels 1. The metabolic activity was measured in the remaining three vessels. The results are shown in Table 1. The metabolic activity values are shown in Table 1 as the average values of the results for the three vessels. Furthermore, the cell adhesion of the remaining vessel was evaluated after 7 days of culture. The results are shown in Table 1. Figure 2 shows the results of observing the cells one day after cell seeding with a phase contrast microscope.
[実施例2]
レーザー加工条件を出力100mW、ビーム径20μmに変更した以外は実施例1と同様な方法で細胞培養容器を作成し、孔径が20μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 2]
A cell culture vessel was produced in the same manner as in Example 1, except that the laser processing conditions were changed to an output of 100 mW and a beam diameter of 20 μm. A 24-well cell culture vessel with a hole diameter of 20 μm and a hole density of 0.5 pcs/ cm2 was produced and evaluated. The results are shown in Table 1.
[実施例3]
レーザー加工条件をビーム径40μmに変更した以外は実施例2と同様な方法で細胞培養容器を作成し、孔径が40μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 3]
A cell culture vessel was produced in the same manner as in Example 2, except that the laser processing conditions were changed to a beam diameter of 40 μm, and a 24-well cell culture vessel with a hole diameter of 40 μm and a hole density of 0.5 pcs/ cm2 was produced and evaluated. The results are shown in Table 1.
[実施例4]
レーザー加工条件をビーム径80μmに変更した以外は実施例2と同様な方法で細胞培養容器を作成し、孔径が80μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 4]
A cell culture vessel was produced in the same manner as in Example 2, except that the laser processing conditions were changed to a beam diameter of 80 μm. A 24-well cell culture vessel with a hole diameter of 80 μm and a hole density of 0.5 pcs/ cm2 was produced and evaluated. The results are shown in Table 1.
[実施例5]
PSフィルムに20μm孔を120個形成したこと以外は実施例2と同様な方法で細胞培養容器を作成し、評価を実施した。1ウェル(直径16mmの円形状、面積約2cm2)当たり、5つの細孔(孔径20μm)を形成し、細孔密度が2.5個/cm2の24ウェル細胞培養容器を作成した。細孔は、24ウェル培養プレート枠に穿孔済みフィルムを接着させた際に、各ウェルで図1Cに示す通りに配置されるようにあらかじめ設計しておき、穿孔した。具体的には、円形状のウェル底面の内側に沿う円の中心に細孔を1個、該円の同心円(半径5mm)と、該円の直交する2本の対角線とが交わる位置に細孔を4個配置した。結果を表1に示す。
[Example 5]
A cell culture vessel was prepared and evaluated in the same manner as in Example 2, except that 120 20 μm holes were formed in the PS film. Five pores (pore diameter 20 μm) were formed per well (circular shape with a diameter of 16 mm, area of about 2 cm 2 ), and a 24-well cell culture vessel with a pore density of 2.5 pores/cm 2 was prepared. The pores were designed in advance so that they would be arranged in each well as shown in FIG. 1C when the perforated film was attached to the frame of a 24-well culture plate, and perforated. Specifically, one pore was placed at the center of a circle along the inside of the bottom surface of a circular well, and four pores were placed at the position where a concentric circle (radius 5 mm) of the circle intersects with two diagonals that are perpendicular to the circle. The results are shown in Table 1.
[実施例6]
PSフィルムに20μm孔を480個形成したこと以外は実施例2と同様な方法で細胞培養容器を作成し、評価を実施した。1ウェル(直径16mmの円形状、面積約2cm2)当たり、20個の細孔(孔径20μm)を形成し、細孔密度が10個/cm2の24ウェル細胞培養容器を作成した。細孔は、24ウェル培養プレート枠に穿孔済みフィルムを接着させた際に、各ウェルで図1Dに示す通りに配置されるようにあらかじめ設計しておき、穿孔した。具体的には、円形状のウェル底面の内側に沿う円の、半径1.6mm、3.2mm、4.8mmの同心円上に4個、半径6.4mmの同心円上に8個、それぞれ均等に細孔を配置した。結果を表1に示す。
[Example 6]
A cell culture vessel was prepared and evaluated in the same manner as in Example 2, except that 480 20 μm holes were formed in the PS film. 20 pores (pore diameter 20 μm) were formed per well (circular shape with a diameter of 16 mm, area of about 2 cm 2 ), and a 24-well cell culture vessel with a pore density of 10 pores/cm 2 was prepared. The pores were designed in advance so that they would be arranged in each well as shown in FIG. 1D when the perforated film was attached to the frame of a 24-well culture plate, and perforated. Specifically, 4 pores were arranged evenly on concentric circles with radii of 1.6 mm, 3.2 mm, and 4.8 mm, and 8 pores were arranged evenly on a concentric circle with a radius of 6.4 mm, along the inside of the bottom surface of the circular well. The results are shown in Table 1.
[実施例7]
PSフィルムに20μm孔を2400個形成したこと以外は実施例2と同様な方法で細胞培養容器を作成し、評価を実施した。1ウェル(直径16mmの円形状、面積約2cm2)当たり、100個の細孔(孔径20μm)を形成し、細孔密度が50個/cm2の24ウェル細胞培養容器を作成した。細孔は、24ウェル培養プレート枠に穿孔済みフィルムを接着させた際に、各ウェルで図1Eに示す通りに配置されるようにあらかじめ設計しておき、穿孔した。具体的には、円形状のウェル底面の内側に沿う円の、半径0.8mmの同心円上に4個、半径1.6mm、3.2mmの同心円上に16個、半径4.8mm、6.4mmの同心円上に32個、それぞれ均等に細孔を配置した。結果を表1に示す。
[Example 7]
A cell culture vessel was prepared and evaluated in the same manner as in Example 2, except that 2400 20 μm holes were formed in the PS film. A 24-well cell culture vessel was prepared with 100 pores (pore diameter 20 μm) formed per well (circular shape with a diameter of 16 mm, area of about 2 cm 2 ) and a pore density of 50 pores/cm 2 . The pores were designed and perforated in advance so that they would be arranged as shown in FIG. 1E in each well when the perforated film was attached to the frame of a 24-well culture plate. Specifically, pores were evenly arranged on a concentric circle with a radius of 0.8 mm, 16 on concentric circles with radii of 1.6 mm and 3.2 mm, and 32 on concentric circles with radii of 4.8 mm and 6.4 mm, respectively, along the inside of the bottom surface of the circular well. The results are shown in Table 1.
[実施例8]
PSフィルムに20μm孔を9600個形成したこと以外は実施例2と同様な方法で細胞培養容器を作成し、評価を実施した。1ウェル(直径16mmの円形状、面積約2cm2)当たり、400個の細孔(孔径20μm)を形成し、細孔密度が200個/cm2の24ウェル細胞培養容器を作成した。細孔は、24ウェル培養プレート枠に穿孔済みフィルムを接着させた際に、各ウェルで図1Fに示す通りに配置されるようにあらかじめ設計しておき、穿孔した。具体的には、円形状のウェル底面の内側に沿う円の、半径0.8mm、1.6mm、2.1mm、2.7mmの同心円上に8個、半径3.2mm、3.7mm、4.3mmの同心円上に16個、半径4.8mm、5.3mmの同心円上に32個、半径5.9mm、6.4mm、6.9mm、7.5mmの同心円上に64個、均等に細孔を配置した。結果を表1に示す。
[Example 8]
A cell culture vessel was prepared and evaluated in the same manner as in Example 2, except that 9,600 20 μm holes were formed in the PS film. A 24-well cell culture vessel was prepared with 400 pores (pore diameter 20 μm) formed per well (circular shape with a diameter of 16 mm, area of approximately 2 cm 2 ) and a pore density of 200 pores/cm 2 . The pores were designed and perforated in advance so that they would be arranged in each well as shown in FIG. 1F when the perforated film was attached to the frame of a 24-well culture plate. Specifically, 8 pores were evenly arranged on concentric circles with radii of 0.8 mm, 1.6 mm, 2.1 mm, and 2.7 mm, 16 pores on concentric circles with radii of 3.2 mm, 3.7 mm, and 4.3 mm, 32 pores on concentric circles with radii of 4.8 mm and 5.3 mm, and 64 pores on concentric circles with radii of 5.9 mm, 6.4 mm, 6.9 mm, and 7.5 mm along the inner side of the bottom of the circular well. The results are shown in Table 1.
[実施例9]
細胞播種濃度を1.0×105cells/cm2に変更したこと以外は実施例2と同様な方法で評価を実施した。結果を表1に示す。
[Example 9]
The evaluation was carried out in the same manner as in Example 2, except that the cell seeding concentration was changed to 1.0×10 5 cells/cm 2. The results are shown in Table 1.
[実施例10]
コラーゲン処理を実施しなかったこと以外は実施例3と同様な方法で細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 10]
A cell culture vessel was prepared and evaluated in the same manner as in Example 3, except that the collagen treatment was not performed. The results are shown in Table 1.
[実施例11]
PSフィルムの代わりに厚み50μmのTPXフィルム(以下、PMPと記載する。三井化学東セロ株式会社製、商品名:オピュランX-88B、酸素透過度38240cm3/(m2×24h×atm))を用いたこと以外は実施例2と同様な方法で細胞培養容器を作成し、孔径が20μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 11]
A cell culture vessel was prepared in the same manner as in Example 2, except that a 50 μm thick TPX film (hereinafter referred to as PMP, manufactured by Mitsui Chemicals Tocello Inc., product name: Opulent X-88B, oxygen permeability 38,240 cm 3 /(m 2 × 24 h × atm)) was used instead of the PS film. A 24-well cell culture vessel with a pore size of 20 μm and a pore density of 0.5/cm 2 was prepared and evaluated. The results are shown in Table 1.
[実施例12]
レーザー加工条件をビーム径40μmに変更した以外は実施例11と同様な方法で細胞培養容器を作成し、孔径が40μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 12]
A cell culture vessel was produced in the same manner as in Example 11, except that the laser processing conditions were changed to a beam diameter of 40 μm, and a 24-well cell culture vessel with a hole diameter of 40 μm and a hole density of 0.5 pcs/ cm2 was produced and evaluated. The results are shown in Table 1.
[実施例13]
PSフィルムの代わりに厚み50μmの二軸配向ポリエチレンテレフタレートフィルム(以下、PETと記載する。東レ株式会社製、商品名:ルミラー#50-T60、酸素透過度30cm3/(m2×24h×atm))を用いたこと以外は実施例2と同様な方法で細胞培養容器を作成し、孔径が20μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 13]
A cell culture vessel was prepared in the same manner as in Example 2, except that a 50 μm-thick biaxially oriented polyethylene terephthalate film (hereinafter referred to as PET, manufactured by Toray Industries, Inc., product name: Lumirror #50-T60, oxygen permeability 30 cm 3 /(m 2 × 24 h × atm)) was used instead of the PS film. A 24-well cell culture vessel with a pore size of 20 μm and a pore density of 0.5/cm 2 was prepared and evaluated. The results are shown in Table 1.
[実施例14]
レーザー加工条件をビーム径40μmに変更した以外は実施例13と同様な方法で細胞培養容器を作成し、孔径が40μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、評価を実施した。結果を表1に示す。
[Example 14]
A cell culture vessel was produced in the same manner as in Example 13, except that the laser processing conditions were changed to a beam diameter of 40 μm, and a 24-well cell culture vessel with a hole diameter of 40 μm and a hole density of 0.5 pcs/ cm2 was produced and evaluated. The results are shown in Table 1.
[比較例1]
レーザー加工条件を出力150mW、ビーム径120μmに変更し、コラーゲンコートを実施しなかったこと以外は実施例1と同様な方法で細胞培養容器を作成し、孔径が120μm、孔密度は0.5個/cm2の24ウェル細胞培養容器を作成し、培養評価を実施した。結果を表2に示す。
[Comparative Example 1]
A cell culture vessel was produced in the same manner as in Example 1, except that the laser processing conditions were changed to an output of 150 mW and a beam diameter of 120 μm, and collagen coating was not performed. A 24-well cell culture vessel with a hole diameter of 120 μm and a hole density of 0.5 cells/ cm2 was produced, and culture evaluation was performed. The results are shown in Table 2.
[比較例2]
レーザー加工による細孔を形成していないPSフィルムを用いたこと以外、実施例1と同様な方法で細胞培養容器を作成し、評価を実施した。結果を表2に示す。
[Comparative Example 2]
A cell culture vessel was produced and evaluated in the same manner as in Example 1, except that a PS film without pores formed by laser processing was used. The results are shown in Table 2.
[比較例3]
細胞播種濃度を1.0×105cells/cm2に変更したこと以外は比較例2と同様な方法で評価を実施した。結果を表2に示す。
[Comparative Example 3]
Except for changing the cell seeding concentration to 1.0×10 5 cells/cm 2 , evaluation was carried out in the same manner as in Comparative Example 2. The results are shown in Table 2.
[比較例4]
底面のPSの厚みが1000μmである市販の24ウェルPS培養容器(コーニング社製、酸素透過度200cm3/(m2×24h×atm))を使用した以外は比較例2と同様な方法で細胞培養容器を作成し、評価を実施した。結果を表2に示す。
[Comparative Example 4]
A cell culture vessel was prepared and evaluated in the same manner as in Comparative Example 2, except that a commercially available 24-well PS culture vessel (manufactured by Corning, oxygen permeability 200 cm3 /( m2 x 24h x atm)) with a PS bottom thickness of 1000 µm was used. The results are shown in Table 2.
[比較例5]
細胞播種濃度を1.0×105cells/cm2に変更したこと以外は比較例4と同様な方法で評価を実施した。結果を表2に示す。
[Comparative Example 5]
Except for changing the cell seeding concentration to 1.0×10 5 cells/cm 2 , evaluation was carried out in the same manner as in Comparative Example 4. The results are shown in Table 2.
[比較例6]
レーザー加工による孔を形成していないTPXフィルムを用いたこと以外、実施例11と同様な方法で細胞培養容器を作成し、評価を実施した。結果を表2に示す。
[Comparative Example 6]
A cell culture vessel was produced and evaluated in the same manner as in Example 11, except that a TPX film without holes formed by laser processing was used. The results are shown in Table 2.
[比較例7]
レーザー加工による孔を形成していないPETフィルムを用いたこと以外、実施例13と同様な方法で細胞培養容器を作成し、評価を実施した。結果を表2に示す。
[Comparative Example 7]
A cell culture vessel was produced and evaluated in the same manner as in Example 13, except that a PET film without holes formed by laser processing was used. The results are shown in Table 2.
表1より、本発明の培養部材を培養容器底部に配置した培養容器を用いたラット初代凍結肝細胞の培養では、最長7日間の長期培養が可能であることが示された。また、この培養容器は、底面の撓みは無く、形状安定性に優れ、培地成分の液漏れも無かった。さらに細胞は培養面全体に均一に接着、増殖し、形態を維持しており、この培養容器は細胞接着性に優れていることが示された。 Table 1 shows that long-term culture of frozen rat primary hepatocytes is possible for up to 7 days when using a culture vessel with the culture member of the present invention placed at the bottom of the culture vessel. In addition, this culture vessel had no bending of the bottom, excellent shape stability, and no leakage of culture medium components. Furthermore, the cells adhered and proliferated uniformly over the entire culture surface, maintaining their morphology, demonstrating that this culture vessel has excellent cell adhesive properties.
本発明の培養部材を用いたラット初代凍結肝細胞の培養の効果をより詳細に見ると、培養1日後の培地中酸素濃度が高く、培養部材を介して効果的に酸素が供給されていた。また、肝細胞の機能として薬剤の代謝活性を評価した代謝活性値が高く、細胞の機能は正常に維持されていることが明らかになった。さらに、4×105cells/cm2の高密度培養でも細胞機能を正常に維持させることができることが示された。 Looking more closely at the effect of culturing primary frozen rat hepatocytes using the culture member of the present invention, the oxygen concentration in the medium was high after one day of culture, and oxygen was effectively supplied through the culture member. In addition, the metabolic activity value, which evaluated the metabolic activity of drugs as a function of hepatocytes, was high, and it became clear that the cell function was normally maintained. Furthermore, it was shown that the cell function could be normally maintained even in high-density culture of 4 x 105 cells/ cm2 .
さらに、実施例1~9より、孔径および孔密度を上げることで培養容器底面からの酸素供給能が向上し、飽和酸素濃度が向上し、また、代謝活性値も向上することが示された。 Furthermore, Examples 1 to 9 showed that increasing the pore size and pore density improved the oxygen supply capacity from the bottom of the culture vessel, improved the saturated oxygen concentration, and also improved the metabolic activity value.
一方、比較例1では、孔径が120μmであったため、細孔からの液漏れが生じて、培養評価ができなかった。比較例2~5では、細孔を形成していないポリスチレン容器を用いたため、飽和酸素濃度が低下し、また代謝活性値も低下し、細胞は正常な機能を発現できないことが示された。特に、4×105cells/cm2の高密度培養(比較例2、比較例4)では、さらに代謝活性値が低下し、正常な機能を発現できないことが示された。細孔を形成していないポリエチレンテレフタレート容器を用いた比較例6では、飽和酸素濃度が低下し、また代謝活性値も低下し、細胞は正常な機能を発現できないことが示された。 On the other hand, in Comparative Example 1, since the pore size was 120 μm, liquid leakage occurred from the pores, and culture evaluation was not possible. In Comparative Examples 2 to 5, since a polystyrene container without pores was used, the saturated oxygen concentration and metabolic activity value also decreased, indicating that the cells could not express normal functions. In particular, in the high-density culture of 4×10 5 cells/cm 2 (Comparative Example 2 and Comparative Example 4), the metabolic activity value further decreased, indicating that the cells could not express normal functions. In Comparative Example 6, in which a polyethylene terephthalate container without pores was used, the saturated oxygen concentration and metabolic activity value also decreased, indicating that the cells could not express normal functions.
実施例1~9および比較例2ならびに実施例13、14および比較例6より、培養容器底面に細孔を有する培養部材を用いることで酸素供給能が向上し、飽和酸素濃度が向上し、さらには代謝活性値が向上することが示された。 From Examples 1 to 9 and Comparative Example 2 as well as Examples 13, 14, and Comparative Example 6, it was shown that the use of a culture member having pores on the bottom surface of the culture vessel improves the oxygen supply capacity, improves the saturated oxygen concentration, and further improves the metabolic activity value.
実施例10より、本発明の培養容器は、コラーゲンコートを実施していない場合でも、4×105cells/cm2の高密度培養において、高い飽和酸素濃度および代謝活性値を示すことが明らかになった。 From Example 10, it was revealed that the culture vessel of the present invention exhibited high saturated oxygen concentration and metabolic activity value in high-density culture of 4×10 5 cells/cm 2 even when not collagen-coated.
以上の結果から、本発明の培養部材は、優れた形状安定性、酸素供給性に加え、細胞接着性が良好で、高密度でも細胞等の機能を保持したまま細胞等の培養が可能であることが明らかになった。 These results demonstrate that the culture material of the present invention has excellent shape stability, oxygen supply, and cell adhesion, making it possible to culture cells at high densities while retaining their functions.
Claims (7)
細胞、組織、または器官をその培養面上で培養する培養部材であり、前記培養部材は樹脂を含み、前記培養面は少なくとも1つの細孔を有し、
前記細孔の平均孔径が、0.1~100μmであり、
前記細孔の総開口面積比率(開口面積の1ウェル当たりの合計/培養部材の培養面の1ウェル当たりの総表面積×100(%))が、0.000001~0.3%である、
培養部材。 A culture vessel having at least one well, at least a part or the whole of a bottom surface of which is formed from the culture member described below;
A culture member for culturing a cell, tissue, or organ on its culture surface, the culture member comprising a resin, the culture surface having at least one pore;
The average pore size of the pores is 0.1 to 100 μm,
The total opening area ratio of the pores (total opening area per well / total surface area per well of the culture surface of the culture member × 100 (%)) is 0.000001 to 0.3%;
Culture material.
前記培養面に接触した細胞、組織または器官に酸素を供給する工程;を含む細胞、組織、または器官の培養方法。 A method for culturing a cell, tissue, or organ, comprising: a step of contacting a cell, tissue, or organ with the culture surface of the culture vessel according to any one of claims 1 to 6; and a step of supplying oxygen to the cell, tissue, or organ in contact with the culture surface.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020213855A JP7627566B2 (en) | 2020-12-23 | 2020-12-23 | Culture material and its uses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020213855A JP7627566B2 (en) | 2020-12-23 | 2020-12-23 | Culture material and its uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022099831A JP2022099831A (en) | 2022-07-05 |
| JP7627566B2 true JP7627566B2 (en) | 2025-02-06 |
Family
ID=82269618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020213855A Active JP7627566B2 (en) | 2020-12-23 | 2020-12-23 | Culture material and its uses |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7627566B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120418406A (en) * | 2022-12-21 | 2025-08-01 | 三井化学株式会社 | Culture vessel, method for producing culture vessel, and method for culturing spheroid |
| JP2024123548A (en) * | 2023-03-01 | 2024-09-12 | 株式会社豊田中央研究所 | Cell adhesive support and cell culture method |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001190267A (en) | 2000-01-07 | 2001-07-17 | Mitsui Chemicals Inc | Culture container comprising polyolefin resin composition |
| US20140038221A1 (en) | 2012-02-20 | 2014-02-06 | Magnus BERGKVIST | Bioengineered human trabecular meshwork for biological applications |
| JP2016136871A (en) | 2015-01-27 | 2016-08-04 | 大日本印刷株式会社 | Cell culture substrate having two types of porous film with different pore sizes, and cell culture tool having the same |
| JP2016182091A (en) | 2015-03-26 | 2016-10-20 | 国立研究開発法人産業技術総合研究所 | Cell-culturing apparatus, and cell-culturing method |
| US20170037353A1 (en) | 2015-08-04 | 2017-02-09 | Toyoda Gosei Co., Ltd. | Cell culture device and method of manufacturing the same |
| JP2018166477A (en) | 2017-03-30 | 2018-11-01 | ベセル株式会社 | Cell culture plate, method for producing the same, and cell culture method |
| JP2018183058A (en) | 2015-09-24 | 2018-11-22 | 株式会社村田製作所 | Cell culture method and cell culture device |
| JP2018183062A (en) | 2017-04-24 | 2018-11-22 | 豊田合成株式会社 | Cell culture instrument |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11137241A (en) * | 1997-11-05 | 1999-05-25 | Otsuka Techno Kk | Culturing vessel |
-
2020
- 2020-12-23 JP JP2020213855A patent/JP7627566B2/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001190267A (en) | 2000-01-07 | 2001-07-17 | Mitsui Chemicals Inc | Culture container comprising polyolefin resin composition |
| US20140038221A1 (en) | 2012-02-20 | 2014-02-06 | Magnus BERGKVIST | Bioengineered human trabecular meshwork for biological applications |
| JP2016136871A (en) | 2015-01-27 | 2016-08-04 | 大日本印刷株式会社 | Cell culture substrate having two types of porous film with different pore sizes, and cell culture tool having the same |
| JP2016182091A (en) | 2015-03-26 | 2016-10-20 | 国立研究開発法人産業技術総合研究所 | Cell-culturing apparatus, and cell-culturing method |
| US20170037353A1 (en) | 2015-08-04 | 2017-02-09 | Toyoda Gosei Co., Ltd. | Cell culture device and method of manufacturing the same |
| JP2017029092A (en) | 2015-08-04 | 2017-02-09 | 豊田合成株式会社 | Cell culture device and method for producing the same |
| JP2018183058A (en) | 2015-09-24 | 2018-11-22 | 株式会社村田製作所 | Cell culture method and cell culture device |
| JP2018166477A (en) | 2017-03-30 | 2018-11-01 | ベセル株式会社 | Cell culture plate, method for producing the same, and cell culture method |
| JP2018183062A (en) | 2017-04-24 | 2018-11-22 | 豊田合成株式会社 | Cell culture instrument |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022099831A (en) | 2022-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102646444B1 (en) | Culture material and its uses | |
| Vyas et al. | Engineering the vasculature with additive manufacturing | |
| CN103814125B (en) | Adhesive cell culture method | |
| JP7627566B2 (en) | Culture material and its uses | |
| Yoo et al. | Use of elastic, porous, and ultrathin co‐culture membranes to control the endothelial barrier function via cell alignment | |
| Rayatpisheh et al. | Argon‐Plasma‐Induced Ultrathin Thermal Grafting of Thermoresponsive pNIPAm Coating for Contractile Patterned Human SMC Sheet Engineering | |
| JP2008061609A (en) | Method for producing cell-culturing container and cell culturing container | |
| CN113846016A (en) | A high-throughput porous array chip, device, preparation method and application | |
| JP2024001173A (en) | Culture vessel and culture method | |
| Salehi et al. | An imprint-based approach to replicate nano-to microscale roughness on gelatin hydrogel scaffolds: surface characterization and effect on endothelialization | |
| Iwai et al. | Induction of cell self‐organization on weakly positively charged surfaces prepared by the deposition of polyion complex nanoparticles of thermoresponsive, zwitterionic copolymers | |
| Fucina et al. | Melanoma growth in non-chemically modified translucid bacterial nanocellulose hollow and compartimentalized spheres | |
| US20250333673A1 (en) | Culture vessel, method for producing same, and culture method | |
| JP2012090587A (en) | Cell culture substratum and method for producing the same | |
| JP2008220205A (en) | Container for forming neural stem cell aggregate, method for producing the same and method for preparing neural stem cell aggregate | |
| CN116583595A (en) | Culture Components and Their Uses | |
| JP6806058B2 (en) | Extracellular matrix production promoting method, cell culturing method, and extracellular matrix production promoting agent | |
| JP2008178367A (en) | Culturing container for developing embryoid, method for producing the same and method for developing the embryoid | |
| Mancinelli et al. | Recreating cellular barriers in human microphysiological systems in-vitro | |
| Jiang et al. | Patterned growth of vascular cells on chemically heterogeneous surfaces modified with heparin-mimicking polymers | |
| JP2010200679A (en) | Cell culture container, method for performing cell culture, and method for evaluating cell | |
| Kabboul | 3D bioprinted cardiac patches for cardiovascular regenerative medicine | |
| Gilmour et al. | Plasma processes for the creation of customizable bio-instructive surfaces and interfaces | |
| JP7219891B2 (en) | LAMINATE FOR CELL CULTURE, MEDICAL DEVICE AND METHOD FOR USING MEDICAL DEVICE | |
| Alshehhi | DEVELOPMENT AND CHARACTERIZATION OF BIOMIMETIC STRUCTURES FOR USE IN 3D IN VITRO MODELS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231030 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240726 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240730 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240927 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241030 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250114 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250127 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7627566 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |